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ABSTRACT 
 
 
Regulatory T-cells (Treg) play an important role in maintaining immune tolerance 
to self-antigens and in suppressing excessive immune responses in the host.  The source, 
specificity, and plasticity of the forkhead box transcription factor 3 (Foxp3+) Treg and 
conventional T (Tconv) cell populations active at sites of autoimmune pathology are not 
well characterized.  To evaluate this, we combined global repertoire analyses and 
functional assessments of isolated T-cell receptors (TCR) from TCR retrogenic mice 
with autoimmune encephalomyelitis (EAE).  Treg and Tconv cell TCR repertoires were 
distinct, and autoantigen-specific Treg and Tconv cells were enriched in diseased tissue.  
Autoantigen sensitivity and fine specificity of these cells intersected, implying that 
differences in responsiveness were not responsible for lineage specification.  Notably, 
autoreactive Treg and Tconv cells could be fully distinguished by an acidic versus 
aliphatic variation at a single TCR CDR3 residue.  Our results imply that ontogenically 
distinct Treg and Tconv cell repertoires with convergent specificities for autoantigen 
respond during autoimmunity and argue limited plasticity between Treg and Tconv cells 
during autoimmune inflammation. 
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CHAPTER 1.  INTRODUCTION 
 
 
1.1 An Introduction to Experimental Allergic Encephalomyelitis (EAE) 
 
Experimental allergic encephalomyelitis (EAE) is a demyelinating disease of the 
central nervous systems.  For over half a century, it has been used as an animal model of 
human MS.  EAE can be induced in different species including mice, rats, guinea pigs, 
rabbits, macaques, rhesus monkeys and marmosets, among which mice and rats are the 
most commonly used species due to their low cost, ready availability, lifespan and large 
number of genetically modified strains.  EAE can be an acute, chronic, or relapsing-
remitting type disease depending on the induction method and types of animal.  For 
example, C57BL/6 mice develop EAE 8-14 days after immunization and may remain 
paralyzed for a prolonged period (Mendel et al., 1995).  In contrast, SJL mice resemble 
the remitting-replapsing form of MS, with alternating episodes of paralysis and recovery 
(Whitham et al., 1991). 
 
EAE is most commonly induced in mice by immunization with CNS-derived 
auto-antigens in complete Freund’s adjuvant (CFA).  Myelin oligodendrocyte 
glycoprotein (MOG35-55), myelin proteolipid protein (PLP139-151) and myelin basic protein 
(MBP1-9) are immunodominant epitopes in the C57BL/6, SJL and B10.PL mice strains 
respectively (Zamvil and Steinman, 1990).  Alternatively, passive transfer of restimulated 
T-cells that recognize myelin autoantigens can also induce EAE (Yoshizawa et al., 1998; 
Zamvil et al., 1985).  Disease progression can be monitored by clinical observation, as an 
ascending paralysis or paresis develops in affected animals.  The following scoring 
system is most commonly applied (Table 1-1). 
 
 
1.1.1 EAE Pathogenesis 
 
In the healthy individual, lymphocytes traffic into the central nervous system 
(CNS) is tightly restricted by the blood-brain barrier (BBB).  After immunization with 
 
 
Table 1-1. EAE clinical score. 
 
 
 
 
 
 
 
 
 
 
Score Clinical Symptoms 
0 Healthy 
1 Limp tail, loss of tail tone 
2 Limp tail and hind limb paraparesis 
3 Complete hind limb paralysis 
4 Complete hind limb and partial front limb paralysis 
5 Morbid 
2 
 
 
MOG35-55 in CFA, circulating lymphocytes and monocytes traffic across the BBB.  T-
cells are restimulated by myelin presented by dendritic cells in the CNS, resulting in 
inflammation and demyelination.  The recruitment process is mediated by the sequential 
interaction of different adhesion molecules on lymphocytes and the inflamed BBB.   
 
During the course of EAE, CNS endothelium upregulates expression of inter-
cellular adhesion molecule (ICAMT)-1 and vascular cell adhesion molecule (VCAM)-1 
(Engelhardt, 2006; Steffen et al., 1994).  Activated myelin-specific T-cells upregulate 
adhesion molecules and chemokine receptors, allowing them to adhere and transmigrate 
through the endothelium (Alt et al., 2002).  Blocking antibodies against VCAM-1 or its 
ligand, 4-integrins, inhibits the development of EAE and inflammatory T-cell 
accumulation in the CNS, implying that the recognition of VCAM-1/4-integrins 
mediates the adhesion of T-cells to inflamed CNS vessels (Engelhardt et al., 1998).  
Lymphoid chemokines CCL19 and CCL21 are also found to be expressed in BBB  
endothelium and CNS venules during EAE (Alt et al., 2002).  Their common receptor 
CCR7 is detected on encephalitogenic T-cells.  Functional ablation of CCR7 or blocking 
CCL19 and CCL21 reduces the accumulation of T-cells to inflamed venules in the CNS, 
suggesting that CCL19 and CCL21 are involved in the recruitment of encephalitogenic T-
cells.  Besides, the b2-integrin LFA-1expressed on encephalitogenic T-cells was required 
for transendothelial migration by engaging with endothelial ICAM-1 and/or ICAM-2 
(Laschinger et al., 2002; Lyck et al., 2003).   
 
The key histopathologic feature of EAE is the destruction of the axonal myelin 
shealth in the CNS.  This histopathology mimics that seen in MS, with T-cell and 
macrophage dominated inflammation, extensive demyelination, axonal and neuronal 
damage.  CD4+ T-cells, CD8+ T-cells, B-cells and activated microglia/macrophages are 
responsible for the lesion development in patients with MS.  One difference in most, but 
not all mouse systems, is an increased reliance on CD4+ T-cells and macrophages, with 
smaller roles for CD8+ T-cells and B lymphocytes, though in some cases polymorphs are 
also detected in acute EAE lesions (Sobel and Kuchroo, 1992).  Most myelin-reactive T-
cells are deleted during thymic development because many myelin antigens were 
expressed in the thymus.  However, the deletion cannot be complete, and auto-reactive T-
cells escaping negative selection constitute the peripheral T-cell repertoire and must be 
kept in check by peripheral tolerance.  In EAE, auto-reactive T-cells have to be activated 
by local antigen presenting cells (APCs) and appropriate costimulatory molecules (Chang 
et al., 1999), then migrate across the BBB into the CNS to initiate inflammation and 
tissue injury.   
 
 
1.1.2 TCR Repertoire Development 
 
 
1.1.2.1 Thymocyte Development 
 
The T-cell receptor (TCR), expressed on the surface of T-lymphocytes, is 
responsible for antigen recognition.  It is a heterodimer composed of two distinct chains, 
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α and β chain in 95% of T-cells, and γ and δ chains in 5% of T-cells (Davis et al., 1998).  
The  TCR requires coexpression of invariant CD3 polypeptides, a collection of protein 
dimers (γε, δε and ζζ).  That associate with the or γδchains.  Neither CD3 nor  
dimer are expressed on the cell surface separately, and the partner proteins are required to 
prevent the isolated protein from degradation (Manolios et al., 1991).  The Ig-like  
heterodimer is responsible for antigen recognition.  Transfection of cDNAs encoding  
and  chains from one T-cell clone into another results in the transfer of reactivity to both 
peptide antigen and MHC (Dembic et al., 1986).  Antibodies directly stimulating the CD3 
molecules elicit the same T-cell activation as stimulation with pMHC.  The CD3 
molecules initiate signal transduction upon antigen recognition.  This process relies on 
the cytoplasmic domains of the CD3 molecules which contain immunoreceptor tyrosine-
based activated motifs (ITAMs).  Activation of T-cells leads to phosphorylation of these 
residues and their association with protein tyrosine kinases (PTKs), such as tyrosine-
protein kinase (fyn), leukocyte-specific protein tyrosine kinase (lck), and zeta-chain 
associated protein kinase (ZAP-70), that further propagate the signal into the cell (Figure 
1-1). 
 
Similar to immnologlobulin heavy and light chains, all TCR polypeptides have 
distinct variable (V) and joining (J) regions.  In addition to V and J segment, the TCR 
contains diversity (D) segments.  During the T-cell development in the thymus, -chain 
genes undergo rearrangement.  First, a D locus rearranges to a J locus, then these 
associate with a V.  If the rearrangement produces an in frame TCR, the functional  
chain will pair with a surrogate  chain, Pre-T-cell  (pT), and is expressed on the cell 
surface along with the CD3 molecules.  Failure to successfully rearrange a  chain leads 
to clonal deletion.  The assembly of the CD3: pTleads to cell proliferation, the arrest of 
further  chain rearrangement and the expression of CD8 and CD4.  In the double 
positive thymocytes, TCR rearrangement must be followed by a successful TCR gene 
rearrangement within approximately 3 days after the proliferative burst.  Otherwise, cells 
die of “neglect”.  The double positive thymocytes express a low level of T-cell receptors 
and must pass a second TCR dependent checkpoint – positive selection.  The criteria here 
are more stringent than for  selection.  They require both a translatable protein coding 
sequence and recognition of self MHC molecules.  If the TCR cannot bind to self MHC 
molecules, it will be neglected and die.  Cells passing positive selection express high 
levels of the TCR, and undergo negative selection, in which self reactive cells are 
eliminated.  These critical developmental checkpoints yield a TCR repertoire that can 
respond to a variety of foreign antigens, but minimizes self-reactivity.  Only 5% of the 
double positive cells satisfactorily pass the checkpoints and mature into single positive T-
cells that exit the thymus and populate the periphery.   
 
 
1.1.2.2 TCR Repertoire Diversity 
 
TCR repertoire diversity results from combinatorial diversity and junctional 
diversity.  Combinatorial diversity is generated by somatic recombination from multiple 
germline gene segments.  The mouse TCRα locus has ~100 Vα (TRAV) gene, and ~50 Jα  
4 
 
 
 
 
 
 
Figure 1-1. Signaling cascades stimulated by the T-cell receptor. 
Adapted with permission.  Razzaq, T.M., Ozegbe, P., Jury, E.C., Sembi, P., Blackwell, 
N.M., and Kabouridis, P.S. (2004).  Regulation of T-cell receptor signalling by 
membrane microdomains.  Immunology 113, 413-426. 
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(TRAJ) gene segments.  The TCRβ locus has 25 Vβ (TRBV), 2 Dβ (TRBD) and 12 Jβ 
(TRBJ) gene segments.  The maximum number of possible combinations of these gene 
segments is the product of the numbers of V, J and D segments in each locus.  The 
diversity implied therein would be much less than the actual diversity of antigen 
receptors in mature lymphocytes.  In fact, a large contribution to the TCR diversity is 
made by the removal or addition of nucleotides between V and D, D and J, or V and J 
segments at the time of joining, namely, junctional diversity.  Nucleotides (P sequences) 
may be added to broken DNA ends to repair asymmetric RAG-mediated cleavage.  Other 
nucleotides (N regions) may be added to the sites of VD, VJ, or DJ junctions by the 
action of the terminal deoxyribonucleotidyl transferase (TdT), generating new sequences 
that are not present in the germline (Figure 1-2).  In addition, random paring of α and β 
chains introduces additional diversity.  Taking all these factors together, a theoretical 
maximum diversity is 1015 unique TCR.  In the thymus, 95% of the precursor cells are 
eliminated through both positive and negative selection.  This still leaves more than 1013 
possible TCRs that can be produced.  The actual diversity of the naive mouse spleen T-
cell repertoire is estimated to be ~2 x 106 using the immunoscope technique, suggesting 
the average size of a clone expressing a single TCR is ~10 cells in spleen (Casrouge et al., 
2000). 
 
TCR diversity is localized to complementarity-determining regions (CDRs) on 
both chains.  CDR1 and 2 regions, encoded by the V gene segment, are responsible for 
interacting with MHC molecules; whereas the CDR3 is the most variable part of the TCR.  
It is encoded by the juxtaposition of rearranged V-(D)-J or V-J segments.  CDR3 forms a 
flexible loop positioned to associate with the peptide-MHC complexes.  Characterization 
of CDR3 sequence variation therefore provides a good measure of TCR diversity in an 
antigen selected repertoire. 
 
Because many more TCRs may form than the number of T-cell clones that enter 
the circulation, there are huge differences between repertoires among individuals.  In 
most T-cell responses, the TCR repertoires consist of TCRs with private specificity, that 
is TCR only observed within one individual.  In addition public or shared TCRs among 
multiple individuals may be seen.  Public TCRs are observed in both acute and persistent 
pathogen infection and autoimmune diseases such as EAE.  Why they exist is unclear.  A 
potential explanation is certain bias promotes selection of certain TCR.  That includes 
unique structural features of TCR or the pMHC complex, biased TdT activity and 
convergent recombination, and selective expansion in periphery. 
 
 
1.2 Regulatory T-cells 
 
T-cells are crucial to adaptive immunity and function both as effector cells and 
helper cells in humoral and cell mediated responses.  The activated immune system also 
requires homeostatic control mechanisms to down-regulate over-exuberant immune 
responses.  Tolerance to self-antigens includes a central and a peripheral component.  
Central tolerance refers to negative selection of auto-reactive T-cells in thymus.  
Peripheral tolerance consists of T-cell deletion, T-cell anergy and regulatory T-cell (Treg)  
6 
 
 
 
 
 
Figure 1-2. Generation of T-cell receptor diversity by somatic recombination of 
TCR gene segments.   
Reprinted with permission.  Turner, S.J., Doherty, P.C., McCluskey, J., and Rossjohn, J. 
(2006).  Structural determinants of T-cell receptor bias in immunity.  Nat Rev Immunol 
6, 883-894. 
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suppression in the periphery (Miller and Heath, 1993; Schwartz, 1990).  In mouse 
neonatal thymectomy (nTx) studies, nTx on the third day of life (d3Tx), but not d1Tx or 
d7Tx, developed on autoimmune disease that could be prevented by thymus transplant or 
CD4+ T-cell reconstitution from normal adult mice (Nishizuka and Sakakura, 1969).  
This suggested that autoreactive T-cells were exported from the thymus earlier than the 
suppressor cells, and that these cells were also CD4+ T-cells. 
 
Sakaguchi et al. first proposed that a subset of CD4+ T-cells, that constitutively 
express the CD25 antigen (IL-2R chain), function as regulatory T-cells in the normal 
mouse (Asano et al., 1996; Sakaguchi et al., 1995; Suri-Payer et al., 1998).  Depletion of 
CD4+CD25+ T-cells leads to organ specific autoimmune disease in mice, and adoptive 
transfer of the CD25+ cells prevent autoimmunity.  CD4+CD25+ T-cells represent 10%-
15% of mouse CD4+ lymphocytes, and 5%-10% of CD4+ SP thymocytes.  Compared 
with CD4+CD25- T-cells, CD4+CD25+ T-cells express slightly higher levels of CD5, 
cytotoxic T-lymphocyte antigen (CTLA-4) and glucocorticoid-induced TNF-like receptor 
(GITR), lymphocyte-activation gene (LAG-3), 4-1BB, CD28, CD134, CD80/86 (B7) as 
well as intermediate and low levels of CD45RB. However, none of those is restricted to 
Treg cells (Ndhlovu et al., 2004; Paust et al., 2004; Workman et al., 2009).  One unique 
feature of Treg cells is that they express the X chromosome-encoded forkhead 
transcription factor 3 (Foxp3), which serves as a key player in the biology of CD4+CD25+ 
Treg cells (Brunkow et al., 2001; Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 
2003).  Expression of Foxp3 is largely restricted to Treg cells and requires Treg cell 
differentiation (Fontenot et al., 2003; Fontenot et al., 2005b; Hori et al., 2003; Wan and 
Flavell, 2007).  IPEX syndromes (immune dysregulation, polyendocrinopathy, 
enteropathy, X-linked) in humans and scurfy mice have mutations in the Foxp3 gene.    
Foxp3 deficient mice show defects in Treg development, and retroviral transduction of 
Foxp3 into naive CD25- T-cells led to the acquisition of suppressor activity both in vitro 
and in vivo (Fontenot et al., 2005b).   
 
 
1.2.1 Suppressor Mechanisms Utilized by Regulatory T-cells 
 
Defining the mechanisms of Treg suppressive function is crucial in understanding 
of peripheral tolerance.  It has been shown that Treg cells utilize multiple means to limit 
immune responses, such as suppression by cell contact-dependent cytolysis on responder 
T-cells or APCs, suppression by inhibitory cytokines or deprivation of cytokines, 
suppression by surface molecules (CTLA-4 or GITR), and suppression by modulation of 
dendritic cell maturation (Vignali et al., 2008). 
 
 
1.2.1.1 Role of Cytolysis 
 
An early study has shown that CD25+ T-cells were unable to suppress the in vitro 
proliferation of responder CD4+CD25- T-cells when the two populations were separated 
by a semi-permeable membrane.  This suggests that suppression requires cell contact or 
close proximity between Treg cells and their targets (Thornton and Shevach, 1998).  
8 
 
 
Human activated CD4+CD25+Foxp3+ Treg cells express granzyme A and kill activated 
CD4+ and CD8+ T-cells in a perforin-dependent, Fas-FasL-independent manner.  
Activation of mouse Treg cells also results in up-regulation of granzyme B expression 
(Gondek et al., 2005; Grossman et al., 2004).  However, another study demonstrated that 
highly activated Treg cells could kill APCs but not bystander B-cells or T-cells in a cell-
contact-dependent manner (Zhao et al., 2006).  Besides granzyme A and B, a recent study 
showed that galectin-1, which can induce T-cell apoptosis, was up-regulated in human 
and mouse Treg cells, and galectin-1 deficient Treg cells have reduced suppressive 
function in vitro (Garin et al., 2007).  Nevertheless, these studies suggest more work is 
needed to determine whether Treg cells can develop into cytotoxic cells in vivo and the 
cytolytic mechanisms.  
 
 
1.2.1.2 Role of Immunosuppressive Cytokines 
 
In vivo studies have shown that the inhibitory cytokines such as IL-10, 
transforming growth factor (TGF- are required for Treg mediated suppression in some 
disease models.  In allergy and asthma models, Treg cells control disease in a manner 
partially dependent on IL-10 (Hawrylowicz and O'Garra, 2005) or on both IL-10 and 
TGF-(Joetham et al., 2007).  In colitis studies, administration of a blocking anti-IL-10 
receptor mAb abrogated suppression of colitis by CD4+CD45RBlow T-cells, and Treg 
cells from IL-10 deficient mice failed to suppress colitis, although they suppress 
autoimmune gastritis (AIG) (Asseman et al., 1999).  In EAE model, Treg cells have been 
shown to produce IL-10 in CNS during recovery phase (Kohm et al., 2002; Korn et al., 
2007; McGeachy et al., 2005).  One study showed that Treg cells from IL-10 deficient 
mice were unable to suppress active EAE (Zhang et al., 2004).  However, the Treg cell-
specific ablation of IL-10 showed no spontaneous systemic autoimmunity, but result in 
enhanced pathology in the mucosal surface of the intestine and the lung (Rubtsov et al., 
2008).  Production of TGF- by Treg cells is also shown indispensable for suppression of 
colitis (Fahlen et al., 2005; Zwar et al., 2006).  However, other studies have failed to 
identify the role for TGF- in Treg-mediated suppression in IBD.  In this study, Treg 
cells from neonatal TGF-1 deficient mice can still suppress the incidence and severity of 
IBD (Kullberg et al., 2005).  Taken together, these findings suggest that the importance 
of IL-10 and TGF- in Treg mediated suppression is dependent on the environment and 
experimental setting. 
 
In contrast to the in vivo studies, there is little evidence that suppressive cytokines 
play a role in Treg-mediated suppression in vitro.  For example, the addition of 
neutralizing anti-IL-10 or anti-IL-4 antibodies to in vitro cultures failed to abrogate 
suppressive effects of Treg cells.  And CD4+CD25+ T-cells purified from mice deficient 
in IL-4 or IL-10 showed comparable suppression to wild-type Treg (Thornton and 
Shevach, 1998).  The role of TGF- in suppression is ambiguous.  One study showed that 
inhibition of in vitro suppression was observed in the presence of high concentrations of a 
neutralizing anti-TGF- antibody, and the author proposed that Treg cells exert 
suppression by a cell-cell interaction involving cell surface TGF-1 (Nakamura et al., 
2001).  However, subsequent analyses have shown that responder T-cells from dominant-
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negative TGF- receptor mice were fully susceptible to suppression by Treg cells in vitro.  
Furthermore, Treg cells from neonatal TGF-1 deficient mice were as suppressive as 
Treg from wild-type mice, confirming TGF- is not critical to the suppression by Treg 
cells in vitro (Piccirillo et al., 2002).  Studies demonstrated that the suppressor function 
of activated Treg cells in vitro is antigen nonspecific.  When Treg cells from TCR 
transgenic mice were activated and expanded in vitro, the activated suppressors were able 
to inhibit fresh CD4+CD25- T-cells specific for different antigens (Thornton and Shevach, 
2000).  Collectively, these studies demonstrated that the suppressive effects of Treg cells 
in vitro are less likely cytokine dependent and antigen non-specific.   
 
Recently, a novel inhibitory cytokine, IL-35, has been described that is 
specifically produced by Treg and is required for maximal regulatory activity (Collison et 
al., 2007).  Ectopic expression of IL-35 confers regulatory activity on naïve T-cells and 
recombinant IL-35 suppresses T-cell proliferation in vitro.  A later study showed Treg 
cells expressed substantial IL-35 following contact with Tconv cells, and this potent 
suppression was in a cell contact, IL-35 and IL-10 dependent manner (Collison et al., 
2009).  Although the identification of IL-35 brings new information to Treg cell portfolio, 
there is much more that remains to be defined, such as its contribution to Treg function in 
vivo, or whether IL-35 plays a role in the development and function of DCs and 
macrophages. 
 
IL-2 was identified as a T-cell growth factor many years ago (Schimpl and 
Wecker, 1972).  Treg cells do not produce IL-2, but express high affinity IL-2 receptor 
(CD25).  Therefore it was hypothesized that Treg cells may efficiently consume IL-2 and 
suppress proliferation of responder T-cells by competing for IL-2 in the local 
environment.  However, this proposal is not supported by the Treg cells present in IL-
2R-/- mice that display similar in vitro suppressor activity to the wild-type counterpart 
(Fontenot et al., 2005a).  Therefore IL-2 responsiveness is dispensable in Treg 
suppression, but is crucial for the maintenance of Treg cells. 
 
 
1.2.1.3 Role of CTLA-4 and GITR 
 
Cytotoxic T-lymphocyte antigen4 (CTLA-4) is generally expressed on activated 
CD4+ T-cells, and it transduces a negative signal that results in dampening of T-cell 
activation following binding to CD80/CD86 ligands on APC (Oosterwegel et al., 1999).  
CD25+ Treg cells constitutively express CTLA-4, suggesting its importance in Treg 
biology.  This hypothesis was supported in the study that the addition of anti-CTLA-4 
antibody or its Fab fragment abrogated CD25+ Treg mediated suppression of responder 
CD4+ T-cell proliferation in vitro (Takahashi et al., 2000).  However, this result has been 
difficult to reproduce by other groups (Thornton and Shevach, 1998).  The role of CTLA-
4 in Treg function is further supported by in vivo studies.  For example, anti-CTLA-4 
treatment abrogated Treg cells suppressing inflammatory bowel disease (IBD) (Read et 
al., 2000), or induced AIG in BALB/c mice, suggesting that interaction between CTLA-4 
and CD80/CD86 is required for Treg suppression effects.  Although these findings 
indicated that the dispensable role of CTLA-4 signaling in CD25+ Treg suppressive 
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function in vivo, the action site of anti-CTLA-4 antibody remains unclear, and it is 
possible that the antibody targeted the activated CD4+ T-cells rather than the CD25+ Treg 
cells. 
 
Like CTLA-4, GITR is also expressed on both Treg and activated CD4+CD25- T-
cells (Shimizu et al., 2002).  The ligand for GITR is expressed on endothelial cells, APC 
and dendritic cells.  In vitro studies showed that the ability of Treg cells to suppress the 
proliferation of co-cultured CD25- T-cells was abrogated in the presence of anti-GITR 
antibody, indicating the important role of GITR stimulation in Treg cell suppressive 
function in vitro (McHugh et al., 2002; Shimizu et al., 2002).  The action site of anti-
GITR antibody was determined using CD25+ Treg cells and responder T-cells from wild-
type and GITR deficient mice.  Ligation of GITR on CD25- responders, but not CD25+ 
Treg cells, was required to abrogate suppression.  Thus the interaction of GITR on 
effector T-cells with its ligands mediates resistance to suppression by Treg cells. 
 
 
1.2.1.4 Effects on APC 
 
Suppression may result from down-modulation of the capacity of APC to activate 
effector T-cells, or competition between CD25+ Treg cells and Tconv cells for co-
stimulatory molecules expressed on APC.  Several studies have reported that Treg cells 
could down-regulate the expression of co-stimulatory molecules CD80/CD86 by DCs 
(Cederbom et al., 2000; Houot et al., 2006; Kryczek et al., 2006; Serra et al., 2003).  
However, activation of CD25+ Treg suppressor function did not require co-stimulation by 
CTLA-4 interaction with CD80/86 (Thornton et al., 2004).  CD25+ Treg cells were able 
to suppress CD8+ T-cell proliferation in APC-free system in vitro, suggesting that APC 
are not required for suppression and the suppression may involve direct interaction 
between Treg and effector T-cells (Piccirillo and Shevach, 2001).  Therefore competition 
for co-stimulation is unlikely to be a major mechanism of suppression.  Recent studies 
have shown that lymphocyte-activation gene 3 (LAG-3) may block DC maturation.  
LAG-3, expressed on CD25+ Treg cells, is a CD4 homologue that binds MHCII 
molecules and has a negative regulatory function which is required for maximal Treg cell 
suppression (Huang et al., 2004; Workman and Vignali, 2005).  Engagement of LAG3 to 
MHCII molecules expressed by immature DCs induces an immunoreceptor tyrosine-
based activation motif (ITAM) mediated inhibitory signaling pathway, that suppresses 
DCs maturation (Liang et al., 2008).  However, more work is required to investigate 
whether and how Treg mediate suppressive function through DCs.   
 
 
1.2.2 Thymic and Extrathymic Origin of Foxp3+ Treg  
 
 
1.2.2.1 Thymic Development of Foxp3+ Treg Cells 
 
In 1969, it was observed that neonatal thymectomy at certain period of time (day 
three after birth) results in autoimmune damage of various organs (Nishizuka and 
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Sakakura, 1969).  Subsequent studies showed that d3Tx induced autoimmunity can be 
prevented by transfer of CD4+ T-cells or CD4+ CD8- thymocytes from syngeneic adult 
mice (Fowell and Mason, 1993; Sakaguchi et al., 1982), or more specifically, by transfer 
of CD25+ Treg cells isolated from normal adult mice (Asano et al., 1996).  This suggests 
that d3Tx mice intrinsically lack CD25+ Treg and provide a clue that Treg cells may 
originate in the thymus.  It is found that nTreg develop in fetal thymic organ cultures 
(FTOC) (Carter et al., 2005; Kim and Rudensky, 2006).  And GFP-Foxp3 knock-in mice 
revealed selection of T-cells into the Treg lineage at the transition from DP to SP 
thymocytes (Hsieh et al., 2006).  Treg cells migration from the thymus to the periphery 
was documented by injection of FITC intrathymically (Papiernik et al., 1998).  
Furthermore, Itoh et al found that CD25+CD4+CD8- thymocytes showed similar in vitro 
functional characteristics as their peripheral counterparts, such as anergic and suppressive 
responses to conventional T-cells (Itoh et al., 1999).  In addition, CD25+CD4+CD8- 
thymocytes display a similar phenotype – expression of CTLA-4, GITR and OX40, as 
peripheral Treg cells (Itoh et al., 1999; Shimizu et al., 2002).  Taking together, these data 
support the thymus is the site of nTreg generation.  Mice deficient in all class II 
molecules did not develop CD4+CD25+ T-cells, while mice expressing MHC class II 
molecules only in the thymic cortex did (Bensinger et al., 2001).  This indicates that the 
development of Treg cells requires interaction with self-antigen-MHCII complexes on the 
thymic APC.   
 
It is not known whether Treg cells undergo positive and negative selection as 
conventional T-cells do.  The induction of Foxp3 in nTreg requires CD28 signaling 
induced by CD80 and CD86 expressed on antigen presenting cells, as Treg cells were 
markedly decreased in CD28 deficient and CD80/86 deficient mice (Salomon et al., 2000; 
Tai et al., 2005).  Additionally, the lck-binding domain of CD28 cytoplasmic tail is 
critical for the induction of Foxp3, therefore suggesting that CD28 signaling is important 
in Treg differentiation in thymus (Tai et al., 2005).  IL-2, IL-2R (CD25) and IL-2R 
(CD122) are important in Treg development.  Mice which lack any of them showed a 
significantly reduced number of thymic and peripheral CD25+ Treg cells and developed 
autoimmunity (Almeida et al., 2002; Malek et al., 2002; Papiernik et al., 1998).  The 
autoimmune diseases could be controlled by reconstitution of these mice with normal 
CD25+ T-cells (Malek and Bayer, 2004).  This suggests that IL-2 signaling was required 
for thymic development of CD25+ T-cells.  Whether TCR on Tregs has a higher affinity 
for self-antigen-MHC complexes than conventional T-cells is still controversial and is 
discussed below. 
 
 
1.2.2.2 Peripheral Generation of Foxp3+ Treg Cells 
 
One important question is whether thymus is the only place for the generation of 
Foxp3+ T-cells.  A number of studies (both in vivo and in vitro) have revealed that 
Foxp3+ T-cells can also be generated extrathymically from peripheral naive CD4+ Foxp3- 
T-cells, called adaptive Treg (iTreg).  A variety of conditions favor iTreg conversion.  
For example, in vitro antigen-stimulation of naive T-cells in the presence of TGF- will 
induce iTreg (Apostolou and von Boehmer, 2004; Chen et al., 2003; Kretschmer et al., 
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2005).  In TGF- dependent in vitro Treg induction, IL-6, an acute phase protein induced 
during inflammation, dampens the conversion from naive T-cells and facilitates T-cell 
differentiation to the Th17 lineage in mice (Bettelli et al., 2006; Veldhoen et al., 2006).  
Genetic deletion or antibody blockage of IL-2 also promotes the differentiation of naive 
CD4+ T-cells into Th17 cells, suggesting that IL-2 facilitates the Treg differentiation but 
inhibits Th17 cell differentiation via signal transducer and activator of transcription 5 
(STAT5) (Laurence et al., 2007).  In addition, the vitamin A metabolite retinoic acid 
(RA), which is produced by a subset of DCs in the gut-associated lymphoid tissue, 
inhibits IL-6 mediated Th17 cell induction.  In the presence of TGF-, RA facilitates the 
differentiation of naive T-cells to Foxp3+ Treg cells (Benson et al., 2007; Coombes et al., 
2007; Mucida et al., 2007; Sun et al., 2007).  Furthermore, naive monoclonal HA-
specific CD4+ T-cells were induced to express Foxp3 under the chronic low dose antigen 
(HA) stimulation.  This suggests that suboptimal co-stimulation is critical for 
differentiation of iTreg (Apostolou and von Boehmer, 2004; Kretschmer et al., 2005).  
Gut-associated lymphoid tissue is a prominent in vivo site for iTreg generation because it 
is enriched in commensal bacteria and food antigens, and CD103+ DCs, which produce 
RA and TGF-, are potent inducers of iTreg.  These dendritic cells are abundant in 
lamina propria (LP) and in the mesenteric lymph node (LN), helping to limit gut 
inflammation through the generation of iTreg.   
 
Early evidence of peripheral conversion of naive CD4+ T-cells into Foxp3+ T-
cells originated from adoptive transfer of polyclonal CD4+CD25- naive T-cells into 
lymphopenic mice.  Part of the donor population became CD25+ Foxp3+ and acquired 
suppressive activity (Curotto de Lafaille et al., 2004).  However, these CD25+ Foxp3+ 
Treg cells might have originated from CD25-Foxp3+ cells present in the initial population.  
To avoid this issue, mature TCR transgenic (Tg) Foxp3- T-cells on a Rag-/- background 
which lack a Foxp3+ component, were transferred into Rag-/- recipients that express 
agonist peptide under control of the Ig promoter.  The injected cells segregated into 
CD25+ (43.5%) and CD25- (56.5%).  Both populations were anergic and suppressive 
(Apostolou et al., 2002).  This suggests that mono-specific naïve T-cells can differentiate 
autonomously into antigen-specific Treg cells in peripheral lymphoid tissue.   
 
However, the extent to which Foxp3- T-cells are converted to Foxp3+ Treg in both 
normal circumstances and autoimmunity remains unclear.  In unimmunized mice, TCR 
repertoire analysis showed distinct populations among Treg and Tconv TCR (Hsieh et al., 
2006; Lathrop et al., 2008; Wong et al., 2007b).  Tracing the Foxp3- Tconv cells which 
were adoptively transferred into normal adult hosts confers different results.  In one study, 
5-12% of transferred CD4+CD25- T-cells express CD25 (Liang et al., 2005), indicating a 
significant contribution of conversion to maintain the peripheral Treg population.  
However, another study showed that average of 0.5% CD4+Foxp3- T-cells converted into 
Foxp3+ T-cells, arguing that peripheral conversion plays a relatively small role in Treg 
pools (Lathrop et al., 2008).  In autoimmune circumstances, sequencing of CDR3a motifs 
from Treg and Tconv cells in BDC2.5/NOD mice, which is a diabetes model, indicated 
that little or no conversion occurs in response to pancreatic auto-antigen (Wong et al., 
2007a).  Foxp3- splenocytes adoptively transferred into congenic hosts followed by EAE 
induction did not convert into Foxp3+ T-cells in spleen and CNS, suggesting conversion 
13 
 
 
was unlikely to occur following immunization of MOG/CFA (Korn et al., 2007).  
Collectively, the role of conversion to contribute to the peripheral Treg population is still 
ambiguous, and we will address this question using repertoire analyses (in Chapter 4) and 
studying specificity of a cohort of individual TCR (in Chapter 5). 
 
 
1.2.3 Specificity of Regulatory T-cells 
 
Affinity based model of Treg development propose that the increased strength of 
TCR and self-peptide-MHC complex favors the selection of Treg and these Treg cells 
have an increased affinity for self antigens.  This is supported by studies with double 
transgenic mice (HA28 x TS1).  When TCR transgenic mice bearing a TCR specific for 
epitope S1 derived from influenza hemagglutinin (HA) were crossed with mice 
expressing HA transgene, the S1-specific T-cells were not deleted and a large proportion 
expressed CD25 and functioned as Treg (Jordan et al., 2001).  Furthermore, thymocytes 
bearing TCRs with low affinity to S1 did not develop into Treg, which suggested that the 
selection of Treg appeared to require a TCR with high affinity for self-antigen-MHC 
complex (D'Cruz and Klein, 2005; Jordan et al., 2001; Kawahata et al., 2002; Lohr et al., 
2003; Walker et al., 2003).  Hsieh et al. directly tested the specificity of Treg cells in vivo 
and in vitro.  He retrovirally transfected different TCRα genes into conventional CD4+ T-
cells of TCli TCR transgenic x Rag-/- mice (TCli TCR is specific for foreign antigen 
human class II-associated Ii peptide), and thus recreated the TCRs derived from either 
CD25- or CD25+ population.  The T-cells expressing Treg TCRs proliferated more 
rapidly than the transductants with Tconv TCRs upon adoptive transfer into lymphopenic 
hosts or in co-cultures with autologous APCs (Hsieh et al., 2004).  Moreover, when the 
TCli TCR transgenic mice were crossed with Foxp3 deficient mice, the autoreactive 
Foxp3-CD25+ T-cells, but not Foxp3-CD25- cells, preferentially used TCRs found in the 
Treg cells in Foxp3 sufficient TCR transgenic mice (Hsieh et al., 2006).  Taken together, 
these results implies that Treg cells express TCRs with increased affinity to self, and 
these TCRs use an overlapping repertoire with pathogenic autoimmune T-cells.   
 
However, an alternative explanation of the Treg percentage increase in the HA28 
x TS1 double transgenic system could be that Treg cells were more resistant to negative 
selection than their Foxp3- counterparts (Bonasio et al., 2006; Liston et al., 2003; van 
Santen et al., 2004).  In experiments where the transgenic TCR was confronted with 
different levels of expression of tetracycline-regulatable neo-self antigen (MCC), the 
proportion of Treg cells increased without a change in absolute numbers.  Thus, selective 
survival might be an alternative explanation for Treg differentiation.  In addition, Treg 
cells can recognize foreign antigen derived from bacteria, viruses and parasites and neo-
antigens.  And analyses of T-cell hybridomas derived from Treg and non-Treg TCRs 
found no evidence that Treg hybridomas preferably recognize self-antigens.  Instead, 
Treg hybridomas recognized foreign MHC-peptide complexes as often as non-Treg cells 
(Pacholczyk et al., 2007).  In conclusion, whether Treg cells possess higher affinity to 
self antigens than Tconv cells is still controversial, and requires further studies to 
determine the affinity range of Treg cells and self reactive Tconv cells. 
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Another important issue is whether antigen specificity of Treg cells is required for 
suppressive function.  In vitro studies indicate that CD25+ Treg cells, once activated, are 
capable of suppressing responder T-cells of disparate antigen specificity (Takahashi et al., 
1998; Thornton and Shevach, 1998).  However, in vivo studies link Treg specificity with 
their activity.  Myelin basic protein (MBP) specific TCR transgenic Treg cells are more 
potent than non-transgenic Treg cells in EAE protection (Hori et al., 2002).  Similar 
findings have been seen in nonobese diabetic (NOD) mice.  In this study, in vitro 
expanded BDC2.5 TCR transgenic Treg cells that are specific for an islet antigen 
expressed in the granules of  cells, suppressed diabetes in NOD Treg deficient mice 
better than expanded polyclonal NOD Treg cells (Tang et al., 2004).  A similar result was 
seen in an autoimmune gastritis (AIG) model, in which antigen-specific induced Treg 
(iTreg) completely prevent AIG while polyclonal iTreg did not (Huter et al., 2008).  In 
contrast, studies of a model of autoimmune uveitis failed to identify tissue specificity 
among involved Treg cells (Grajewski et al., 2006).   
 
 
1.2.4 Regulatory T-cells in MOG-EAE 
 
During autoimmunity, Treg cells substantially accumulate in affected organs.  
Early studies showed that reconstitution of nude mice with CD4+ T-cells depleted for the 
CD25+ subpopulation resulted in the spontaneous development of autoimmune disease 
(Sakaguchi et al., 1995), while replenishment of the CD4+CD25+ T-cells prevented this.  
In EAE, CD25+ T-cells from naive C57BL/6 mice can inhibit both IFN-γ production and 
proliferation of encephalitogenic cells from MOG35-55 immunized mice in vitro.  
Adoptive transfer of these cells can ameliorate or abrogate the severity of EAE (Kohm et 
al., 2002; Mekala et al., 2005; Selvaraj and Geiger, 2008; Tang and Bluestone, 2006; 
Zhang et al., 2004).  On the contrary, depleting functional Treg with anti-CD25 antibody 
(PC61) prior to immunization increases the severity of disease (McGeachy et al., 2005; 
Reddy et al., 2004; Stephens et al., 2005). 
 
During the course of EAE, Treg cells have been identified in the inflamed CNS 
by flow cytometry and histological analysis (Kohm et al., 2006; Korn et al., 2007; Liu et 
al., 2006; McGeachy et al., 2005).  Importantly, the accumulation of Treg cells peaks at 
the recovery phase.  About 30% of these cells can produce IL-10 and these cells 
displayed potent suppressive capacity ex vivo (McGeachy et al., 2005).  The origination 
of these CNS-infiltrating Treg cells is still a puzzle.  One study demonstrated that 
transferred pathogenic T-cells could convert to Foxp3+ phenotype once localized in the 
CNS (Liu et al., 2006).  However, tracking of transferred MOG-specific Tconv cells in a 
passive model, and tracking of transferred polyclonal CD4+Foxp3- T-cells in an active 
model failed to identify the conversion (Davidson et al., 2007; Korn et al., 2007).  The 
previous conversion phenomenon might come from expansion of an already existing 
Foxp3+ population within the transferred “pathogenic” T-cells.  Thus, whether Tconv 
cells can convert to Treg during EAE is still controversial.  Another feature of these 
CNS-infiltrating Foxp3+ Treg cells is their remarkable proliferative capacity, and this 
striking proliferative state is observed in CNS but not in draining lymphoid tissues 
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(O'Connor et al., 2007).  Treg cells are usually anergic when cultured in vitro, and it 
seems the inflammatory environment really promotes their expansion. 
 
Another important question is what antigens CNS-infiltrating Treg cells recognize.  
Isolated Treg cells quickly revert to the classic anergic state in vitro, making antigen 
identification technically challenging to address.  Although some studies showed Treg 
cells may recognize foreign antigens (Pacholczyk et al., 2007), substantial evidence 
indicates that the repertoire also bears an overrepresentation of self-specific TCRs 
(Andersson et al., 2007; Hsieh et al., 2004; Hsieh et al., 2006; Jordan et al., 2001; 
Romagnoli et al., 2002).  Similarly, MOG-specific Treg cells were identified by tetramer 
staining in Foxp3-GFP reporter mice (Korn et al., 2007; Reddy et al., 2004; Reddy et al., 
2005).  Likewise Foxp3+ cells derived from the CNS of MOG immunized mice with EAE 
expanded greatly alter the addition of MOG-peptide to the culture (O'Connor et al., 2007).  
Those studies suggest that CNS-infiltrating Treg cells in MOG-EAE contain at least a 
portion of MOG-reactive cells.   
 
Cross-reactivity is also common in T-cell receptors.  For example, EAE 
spontaneously developed in MOG deficient mice expressing a MOG-specific TCR (2D2).  
This paradox was explained by the finding that 2D2 cells are cross reactive with a 
neuronal cytoskeletal self antigen, neurofilament-M (NF-M) (Krishnamoorthy et al., 
2009).  Even though 2D2 cell belongs to Tconv family, it is possible that CNS-infiltrating 
Treg cells in MOG-EAE also have cross-specificity for additional antigens.   
 
 
1.2.5 Repertoire Analysis of Treg Cells 
 
Although Treg cells are only a small fraction of CD4+ T-cells (5-10%), they can 
respond to a broad spectrum of antigens, both self and foreign.  How does such a limited 
population recognize so many different specificities?  Analyses of  TCR diversity on 
CD4+CD25+ T-cells showed that their repertoire is diverse.  Early studies showed 
TCR repertoire of CD4+CD25+ T-cells is more diverse than the repertoires of natural 
killer T-cells (NK T-cells) (Olivares-Villagomez et al., 2000; Takahashi et al., 1998).  
The comparison of the use of TCR V or V on Tconv and Treg cells revealed similar 
contributions of variable subfamilies to the two subpopulations of T-cells in both mice 
and humans (Fujishima et al., 2005; Kasow et al., 2004; Pacholczyk et al., 2002; 
Romagnoli et al., 2002; Takahashi et al., 1998).  Further analysis of CDR3 size 
distribution showed that the diversity of Treg CDR3 was as broad as Tconv subsets 
(Fujishima et al., 2005; Kasow et al., 2004).   
 
Since each individual can generate millions of different TCRs, CDR3 length 
distribution analysis is not sensitive enough to determine the identity of individual TCRs.  
A more detailed analysis is to sequence individual TCR CDR3 or  regions amplified 
by reverse transcription-polymerase chain reaction (RT-PCR) (Apostolou et al., 2002; 
Hsieh et al., 2004; Hsieh et al., 2006; Pacholczyk et al., 2006; Wong et al., 2007b).  Most 
CDR3 sequence analyses were performed on TCRtransgenic mice, in which all T-cells 
express a single rearranged TCR chain paired with variable TCR chains.  Therefore, 
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the CDR3 can be used as an identifier of individual T-cell clones.  The direct 
comparison of CDR3 sequences among thymic or peripheral Treg and Tconv cells 
suggest that both populations have very diverse repertories.  Interestingly, reduction in 
the diversity of peptide-MHC complexes presented in thymus did not restrict the Treg 
repertoire diversity (Apostolou et al., 2002; Pacholczyk et al., 2006; Wong et al., 2007b).  
This correlated with previous work showing that the proportion of CD4+CD25+ cells 
among CD4+ SP thymocytes remains constant in mice expressing different diversities of 
peptides bound with MHCII molecules (Pacholczyk et al., 2002).  This might suggest that 
the selection of Treg cells is not exclusively dependent on specific high-affinity to 
particular peptide-MHC complexes but rather Treg are selected more loosely as natural 
CD4+ T-cells.  Or alternatively, the diversity of Treg repertoire is reduced in these mice 
with limited thymic antigen diversity, but is still too diverse to be detected by current 
techniques. Because fewer DP thymocytes will pass through positive selection as a result 
of the reduced diversity of peptide-MHC complexes, not only the Treg repertoire but also 
Tconv repertoire will shrink, probably to the same extent, which leads to a similar 
proportion of Treg cells developing. 
 
Analyses of Treg and Tconv repertoires also demonstrates that the Treg and 
Tconv repertoires have partial sequence overlap, ranging from 10 to 42%, depending on 
different experimental strategies (Hsieh et al., 2004; Hsieh et al., 2006; Lathrop et al., 
2008; Pacholczyk et al., 2006; Pacholczyk et al., 2007).  In mice expressing 
unmanipulated polyclonal self antigens on MHCII molecules (Abwt), the overlap is 
approximately 10-20% (Apostolou et al., 2002; Hsieh et al., 2004; Hsieh et al., 2006; 
Pacholczyk et al., 2006).  Whereas in “single-peptide” mice whose MHCII molecules are 
loaded with exclusively one peptide, the overlap increased to 38% (AbEp mice) and 42% 
(H2-DM-deficient mice) (Apostolou et al., 2002; Pacholczyk et al., 2006; Wong et al., 
2007b).  The correlation of increasing overlap with decreasing diversity of selecting 
ligands implies selection of Treg cells is not directly linked to the high self-
reactivity,(Pacholczyk and Kern, 2008) because if Treg cells possess higher self-
reactivity, one should expect more limited overlap in “single-peptide” mice. 
 
This type of repertoire analysis can also be used to survey the interconversion 
between Treg and Tconv cells during the course of autoimmunity.  For example, in a 
diabetes model, only limited Treg and Tconv cell TCR sequence overlap was seen in 
islets, suggesting that the two cell types were not interconverting at the site of 
inflammation (Wong et al., 2007a).   
 
Comparison of the TCR repertoire of Foxp3+ Treg cells present in the thymus and 
the ones present in the periphery showed that the peripheral Treg cells resembled those of 
thymic precursors, and differed from Foxp3- T-cells (Apostolou et al., 2002; Hsieh et al., 
2006; Pacholczyk et al., 2006; Wong et al., 2007b).  These findings support the view that 
the peripheral Treg cells are derived from thymic precursors.  On the other hand, the 
peripheral Treg repertoire does reshape itself somewhat.  For example, TCRs frequently 
found in the thymus are also represented in the periphery, but their dominance may be 
altered (Apostolou et al., 2002; Correia-Neves et al., 2001; Hsieh et al., 2006; 
Pacholczyk et al., 2006; Wong et al., 2007b).  In addition, peripheral interconversion 
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between Treg and Tconv cells is observed, suggesting this conversion process could 
contribute to changes in the peripheral Treg repertoire, compared with thymic Treg 
repertoire.  The peripheral conversion may also play a role in maintenance of the 
peripheral Treg cell population, and might be an important mechanism limiting 
inflammation induced immunopathology, especially in gut – associated lymphoid tissues 
(Coombes et al., 2007; Lathrop et al., 2008; Liang et al., 2005).  However, to what extent 
that the interconversion contributes to peripheral Treg cells in autoimmunity is still 
uncertain. 
 
 
1.3 Summary 
 
Regulatory T-cells, which are recognized as CD4+CD25+Foxp3+ T-cells, are 
critical for immune homeostasis.  They are naturally present in the normal immune 
system as a functionally distinct T-cell subpopulation, and their deficiency produces 
autoimmune disease (Sakaguchi et al., 1995).  Adoptively transferred Treg cells can 
abrogate or prevent organ specific autoimmunity (Kohm et al., 2002; Mekala et al., 2005; 
Selvaraj and Geiger, 2008; Tang and Bluestone, 2006; Zhang et al., 2004).  Thymus is 
the major site of producing Treg cells.  Besides that, peripheral interconversion between 
Treg and Tconv cells is also observed (Coombes et al., 2007; Lathrop et al., 2008; Liang 
et al., 2005), though in different degrees.  During EAE, Treg cells are often found in 
substantial number within affected organs (CNS), and the accumulation is correlated with 
the recovery phase (Korn et al., 2007; Reddy et al., 2004; Yu et al., 2005).  However, the 
origination of these Treg cells and responsiveness difference to Tconv cells are still 
unclear.  In order to solve this issue, we developed a retrogenic mouse model of EAE, 
combined both repertoire analysis and studies of a large cohort of individual TCR.  We 
found that Treg and Tconv cell TCR repertoires have limited overlap within the periphery 
and CNS in mice with EAE, (Chapter 4) and MOG-specific Treg and Teff cells possess 
distinct CDR3 characters but similar sensitivity and fine specificity for MOG 
autoantigen (Chapter 5).   
 
 
 
 
 
 
 
 
18 
 
 
CHAPTER 2.  MATERIALS AND METHODS 
 
 
2.1 Methods of TCR Repertoire Analysis 
 
 
2.1.1 Vector Construction for TCR 
 
Generation of MSCV-IRES-GFP vector was described previously (Persons et al., 
1997).  The GFP was replaced by CFP.  To generate different TCR constructs, the  
chain from 1MOG244.2, 2MOG10, 1MOG9, 1MOG23, and 1MOG213 MOG-specific 
TCR (Alli et al., 2008) were PCR amplified and inserted into EcoRI/XhoI cloning sites in 
the vector (Figure 2-1).   
 
 
2.1.2 Generation of 1MOG244.2TCR Retrogenic Mice 
 
 
2.1.2.1 Retroviral Production and Cellular Transduction 
 
Ten µg of the 1MOG244.2TCR construct DNA and 10µg of retrovirus helper 
DNA constructs PEQPAM were co-transfected into 293T-cells by calcium phosphate 
precipitation as has been described (Geiger et al., 2001).  Briefly, 24 hours prior to 
transfection, 3 x 106 293T-cells were plated on a 10ml tissue-culture treated Petri dish.  
On the day of transfection, four hours prior to transfection, cells were approximately 70% 
confluent.  DNA mix was prepared using 10µg construct DNA and 10µg PEQPAM 
plasmid, 50µl 2.5M CaCl2 and 450µl water at room temperature (RT).  This mix was then 
added to 500µl HPBS (pH 7.2) dropwise while vortexing and incubated 1 minute at RT.  
The whole mixture was added onto 293T-cells and incubated at 37°C.  At 16 hours, the 
cells were washed with PBS to remove Ca2+ and cultured in Dulbecco modified Eagle 
medium (DMEM) with 10% fetal calf serum (FCS), 100 U/ml penicillin G, 100 µg/ml 
streptomycin, 292µg/ml L-glutamine (Invitrogen Life Technologies) at 37°C.  At the 
same time 3 x 105 GP+E86 cells were plated in a 10ml Petri dish.  24 hours later, 
supernatant from 293T-cells was collected, centrifuged at 3000 rotrations per minute 
(rpm) for 7 minutes and the supernatant was used to infect GP+E86 retroviral producer 
cells in the presence of 6µg/ml polybrene (hexadimethrine bromide; Sigma-Aldrich).  
10ml fresh medium was added to 297T-cells, and ready for next time infection.  GP+E86 
cells were infected twice daily for five days.  The GP+E86 cell line was expanded in 
culture for establishing stable retroviral vector producer lines.   
 
 
2.1.2.2 Retroviral Transduction and Transplant of Bone Marrow Cells 
 
GFP-Foxp3 gene-targeted mice were provided by A. Rudensky (U. Washington).  
Tcr-/- mice were obtained from The Jackson Laboratory (Bar Harbor, ME).  These two 
strains were bred to generate GFP-Foxp3 x Tcr-/- mice.  DNA genotyping and flow  
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Figure 2-1. Structure of retroviral constructs.  TCR cDNA sequences were PCR 
amplified with primers containing EcoRI and XhoI sites, and subcloned into the MSCV-
I-CFP retroviral vectors.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
cytometry were performed for screening mice with GFP-Foxp3 gene and TCR-/- gene.  
Genome DNA from each mouse was extracted by Gentra Puregene Mouse Tail Kit 
(Qiagen).  Foxp3 gene was PCR amplified with CW78a and CW78b primers (CW78a, 
5’- TGCCTCTGACAAGAACCCAATGC; CW78b, 5’- 
GGCAGGGGGTTCAAGGAAGAAG).  Nuclease-free water, dNTP mix, buffer with 
MgCl2, Q buffer (Qiagen), Taq polymerase and tail DNA were added to make total of 
50µl PCR mix.  Reactions were carried out using the following PCR parameters: 95°C 
for initial 3 min, 30 cycles of 95°C for 30 sec, 55°C for 30sec, and 72°C for 2.5 min, 
followed by 72°C for 6 min.  The products were analyzed by 1% agarose gel 
electrophoresis.  The knock-in band is 927bp while the WT is 210bp.  To screen TCR-/- 
mice, peripheral blood was collected and RBCs were lysed.  Isolated cells were stained 
with anti-TCR and anti-B220 antibody, and analyzed by flow cytometry.   
 
The production of retrogenic mice has been previously described (Holst et al., 
2006a; Holst et al., 2006b).  Briefly, bone marrow cells were harvested from the femurs 
of GFP-Foxp3 x Tcr-/- mice 48 hr after the administration of 0.15 mg 5-fluorouracil g−1 
body weight, cultured in complete Click's medium (Invitrogen) with 20% FCS, IL-3 (20 
ng ml−1), IL-6 (50ng ml−1), and stem cell factor (50ng ml−1) for 48 hr and then cocultured 
for an additional 48 hr with irradiated (1200 rad) GP+E86 retrovirus producer cells. 
Transduction efficiency was confirmed by flow cytometry with CFP.  Transduced 
progenitor cells were harvested, resuspended in PBS with 2% FCS and heparin 
(10unit/mouse) in total volume of 500ul/mouse, and injected into sublethally irradiated  
(450 rad) Tcr-/- recipients at a ratio of 1.5 recipient mice per bone marrow donor. 
 
To test the engraftment of these retrogenic mice, peripheral blood was collected 
6-8 weeks after transplantation.  Red blood cells were lysed with Gey’s solution (Sigma).  
Isolated cells were stained with anti-CD4 APC and anti-TCR PE antibody, and analyzed 
by flow cytometry. 
 
 
2.1.3 EAE Induction and Clinical Evaluation 
 
MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) was synthesized by the 
St.Jude Hartwell Center for Biotechnology and HPLC purified prior to use.  2mg/ml 
MOG35-55 was resuspended in water, and mixed with an equal volume of complete 
Freund’s adjuvant (CFA) containing 4mg/ml H37RA.  Emulsion was achieved by 
vortexing the mixture for 1hour at room temperature.   
 
EAE was induced on retrogenic mice by s.c. injection of 100µg of MOG35–55 
peptide emulsified in CFA containing 4mg/ml Mycobacterium tuberculosis H37RA 
(Difco). Two hundred nanograms of pertussis toxin (List Biological Laboratories) was 
administered i.v. on days 0 and 2. Clinical scoring was as follows: 1, limp tail; 2, hind 
limb paresis or partial paralysis; 3, total hind limb paralysis; 4, hind limb paralysis and 
body/front limb paresis/paralysis; 5, moribund.  
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2.1.4 Cell Isolation 
 
 
2.1.4.1 Preparation of the Splenocyte Suspension 
 
1MOG244.2 retrogenic mice were sacrificed, spleens were removed and placed 
individually in 6cm diameter dishes.  5ml PBS with 2% FCS were added and completely 
covered the bottom of the dish.  Cells from the splenic capsule were squeezed through the 
70μm nylon mesh by gently mashing spleens with the rubber end of a plunger from a 3cc 
syringe.  A single cell suspension was created and collected into a 50ml conical tube (on 
ice).  5ml PBS with 2% FCS was added to the dish and the whole process was repeated 
twice until the splenic capsules were white, indicating complete release of the cells.  The 
splenocytes were washed by adding 20ml buffer and centrifuged at 350g for 7 min at 4oC 
(Eppendorf centrifuge 5804R with a type A-4-44 swinging bucket rotor). 
 
The supernatant was aspirated and gently resuspended in 3ml/spleen Gey’s 
solution in room temperature for two minutes.  The cells were then washed with 10ml 
PBS buffer and centrifuged again.  Splenocytes were resuspended and passed through a 
70μm nylon mesh strainer into a new 50ml conical tube.  The cell suspension from 
individual mice was pooled in same experiments.  Spleens were prepared individually for 
TCR V usage analysis, and pooled for TCR CDR3 repertoire survey. 
 
 
2.1.4.2 Preparation of the Thymocytes and Lymphocytes Cell Suspension 
 
Mice were sacrificed by CO2 asphyxiation and their thymi, inguinal lymph nodes 
(LNs), axillary LNs, bronchial LNs, superficial and deep cervical LNs, and mesenteric 
LNs were collected.  Similar to splenocytes, thymocytes and lymphocytes were collected 
by passing through 70μm cell meshes, and washed twice with PBS.  Cell suspensions 
were centrifuged at 350g for 10 minutes, pellets resuspended in staining buffer, and 
filtered with a 70μm cell strainer. 
 
 
2.1.4.3 Isolation of CNS-infiltrating T-lymphocytes 
 
Five to six 1MOG244.2 retrogenic mice were immunized with MOG35–55 peptide.  
On day 23-25, the peak phase of EAE disease, the mice were anesthetized with a lethal 
dose of Avertin (0.5ml of 2.5%) delivered by intraperitoneal injection.  When the mice 
were unresponsive to stimulus (no reflex with paw pressure), they were placed on a 
polystyrene board and pinned down.  The abdomen was opened and spleen was gently 
removed.  Then the heart was exposed by cutting up both sides of the rib cage and the 
diaphragm.  The right atrium was cut open with sharp small scissors, a 271/2 g needle was 
immediately inserted into the left ventricle and 10ml chilled PBS slowly pushed into the 
left ventricle.  White lungs indicated a successful perfusion.  The detached head was 
opened by peeling each side of skull back away, and brain was gently removed.  The 
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vertebra was dissected and the lumen was opened, and the spinal cord was collected with 
tweezers.  
 
The CNS tissue was minced and transferred to a 6-well petri dish, digested with 
3ml of 2.5mg/ml collagenase (Worthington Biochemical) and 1mg/ml deoxyribonuclease 
(Sigma) in click’s medium for 25 minutes at 37°C followed by mechanical 
disaggregation.  The disrupted CNS was transferred to a 70μm nylon cell strainer and 
forced through the screen with a 3cc plunge.  The suspension was centrifuged at 400g for 
10 minutes at room temperature.  The pellet was resuspended in 4ml of 80% Percoll 
(Amersham Pharmacia biotech) and underlayed in 4ml of 40% Percoll.  2ml of 100% 
Percoll was used to underlay this.  This gradient was carefully centrifuged at 1200g for 
20 minutes at 20°C.  The cells between the 40% and 80% interface were collected, 
washed twice and resuspended in staining buffer. 
 
 
2.1.5 Cell Counting 
 
A 10µl cell suspension was mixed with 90µl of PBS, and 100µl trypan blue 
solution was added and mixed thoroughly.  A 10µl sample was transferred to a 
hemocytometer chamber.  All viable cells were counted (non-viable cells stain blue, 
viable cells remain opaque) in the four corner squares.  The cell concentration per ml was 
determined using the following calculation. 
 
Cells per ml = the average count per square x the dilution factor x 104 
 
 
2.1.6 Flow Cytometry 
 
 
2.1.6.1 Flow Cytometry (FACS) Analysis of 1MOG244.2 Retrogenic Mice 
 
Eight weeks after hematopoietic progenitor cell (HPC) transfer, five to ten 
retrogenic mice were sacrificed.  Thymocytes were isolated and a single cell suspension 
prepared.  10 x 106 cells were counted and resuspended in 1ml cell staining buffer (500ml 
PBS and 10ml FCS and 5ml 10% sodium azide).  5µg/ml purified anti-mouse 
CD16/CD32 antibody specific for Fcγ R III/I (Miltenyi Biotec) was added and incubated 
for 10 minutes to block nonspecific immunofluorescent staining.  The cells were stained 
with a combination of antibodies, which contained anti-CD4 (clone L3T4), anti-CD8 
(clone 53-6.7), anti-TCR (clone H57-597), anti-CD44 (clone IM7), anti-CD25 (clone 
PC61).  After 20 minutes incubation on ice, the cells were washed three times with 3 ml 
of cell staining buffer.  The cell pellet was resuspended in 0.5ml of cell staining buffer 
and analyzed by flow cytometry (BD FACSCalibur).   
 
A similar preparation was performed with retrogenic splenocytes and CNS-
infiltrating T-cells, but stained with two sets of antibodies.  One set contained anti-CD2 
(clone RM2-5), anti-TCR (clone H57-597), anti-CD25 (clone PC61), and anti-CD4 
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(clone L3T4).  The other set contained anti-CD69 (clone H1.2F3), anti-TCR (clone 
H57-597), anti-CD103 (clone M290), anti-CD5 (clone 53-7.3), and anti-CD4 (clone 
L3T4). 
 
 
2.1.6.2 V Staining of 1MOG244.2 Retrogenic Mice 
 
Splenocytes and CNS-infiltrating T-cells were distributed into 14 wells (96-well 
round bottom plate).  Monoclonal antibody specific for CD4 (clone L3T4) and CD8 
(clone 53-6.7) were added equally.  TCRβ (clone H57-597), TCR Vβ2 (clone B20.6), 
TCR Vβ3 (clone KJ25), TCR Vβ4 (clone KT4), TCR Vβ5.1, 5.2 (clone MR9-4), TCR 
Vβ6 (clone RR4-7), TCR Vβ7 (clone TR310), TCR Vβ8.1, 8.2 (clone MR5-2),  TCR 
Vβ8.3 (clone 1B3.3), TCR Vβ10b (clone B21.5), TCR Vβ11 (clone RR3-15), TCR Vβ12 
(clone MR11-1), TCR Vβ14 (clone 14-2) were added sequentially.  After incubation and 
wash, cells were analyzed by flow cytometry (BD FACSCalibur).   
 
 
2.1.6.3 Cell Separation by Flow Cytometry 
 
At the indicated time points after EAE induction, 5-6 mice/cohort were sacrificed, 
spleens were removed, the circulation perfused with PBS, and brain and spinal cord 
removed.  T-cells were isolated from CNS tissue by density centrifugation as described 
above.  Isolated cells were stained with CD4-specific Ab and immediately sorted into 
Tconv (CD4+GFP-) and Treg (CD4+GFP+) populations with a MoFlo (DakoCytomation) 
or iCyt reflection (iCyt, Champaign, ILL) cell sorter. 
 
 
2.1.7 RNA Isolation and cDNA Transcription 
 
Total RNA was extracted from sorted splenocytes and CNS-infiltrating 
lymphocytes using RNeasy Protect MiniKit (QIAGEN), according to the manufacturer’s 
instructions.  The RNA concentration was determined by NanoDrop ND-1000 
spectrophotometer. 
 
cDNA was immediately generated with the Omniscript RT kit (QIAGEN).  Oligo 
dT, RNase inhibitor, Omniscript reverse transcriptase, 10x buffer, dNTP mix, RNase-free 
water were mixed with RNA, and incubate at 37°C for 1 hour.  The cDNA products were 
kept at -20°C for long term storage. 
 
 
2.1.8 Polymerase Chain Reaction (PCR) Amplification 
 
cDNA was PCR amplified with either Cβ- or Jβ2.7- specific primers (Cβ, 5’- 
CAAGGAGACCTTGGGTGGAGTCACATT; Jβ2.7, 5’-
TAAAACCGTGAGCCTGGTGCCGG) and a Vβ8.2- primer (Vβ8.2, 5’- 
ATGTCTAACACTGCCTTCCCTGACCC).  A bulk reagent tube was created and 
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distributed, which contained nuclease-free water, dNTP mix, buffer with MgCl2 and 
primers.  Then cDNA and high fidelity polymerase (Roche) were added and tubes kept 
on ice.  Five identical and independent PCR reactions were performed with each sample 
per primer pair.  And a reaction without any cDNA was prepared as a negative control.  
The PCR program (Eppendorf Mastercycler gradient) was started, and tubes were placed 
into the machine once the temperature reached 95°C.  Touchdown PCR was used to 
avoid amplifying nonspecific sequences.  The programs were as follows (Table 2-1). 
 
To prevent PCR contamination between experiments, cDNA preparation and PCR 
post-amplification processing were performed in separate areas and using separate 
equipment.  A laminar flow cabinet equipped with UV lamp was also used.  Water, dNTP, 
buffer, tubes, pipette and tips etc were UV irradiated for 15 minutes immediately before 
use.  Fresh gloves, pipette tips with aerosol filters and different sets of pipette were also 
required.  A negative control was always included, in which the reaction mixture did not 
have DNA template.   
 
 
2.1.9 Agarose Gel Electrophoresis and PCR Product Purification 
 
A 1% agarose gel was prepared, and ethidium bromide added after the gel 
solution cooled to 60°C.  A 5µl aliquot from each PCR product was mixed with loading 
buffer and loaded into the gel wells, running at 120V for 30 minutes.  The products were 
examined briefly with a UV transilluminator (Figure 2-2).  A positive reaction contained 
a ~400 bp fragment.  Remaining products underwent a second round of gel 
electrophoresis.  The ~400 bp DNA fragments were excised and purified with the 
QIAquick Gel Extraction Kit, according to the protocol.   
 
 
Table 2-1. PCR program used to amplify CDR3 region. 
 
 Vβ8.2- Jβ2.7 Vβ8.2- Cβ 
1. 95oC 2:00min 1. 95oC 2:00min 
2. 95oC 0:30min 3. 95oC 0:30min 
3. 75oC 0:30min 4. 65oC 0:30min 
4. -1 oC 0:00min 5. -1 oC 0:00min 
5. 72oC 0:30min 6. 72oC 0:30min 
6. Goto 2 repeat 10 cycles 7. Goto 2 repeat 10 cycles 
7. 95oC 0:30min 8. 95oC 0:30min 
8. 65oC 0:30min 9. 55oC 0:30min 
9. 72oC 0:30min 10. 72oC 0:30min 
10. Goto 6 repeat 20 cycles 11. Goto 6 repeat 20 cycles 
11. 72 oC 10:00min 12. 72 oC 10:00min 
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Figure 2-2. PCR amplification of CDR3 region.  Lane 1 and 12: 1kb plus ladder, lane 3 
and 10: 100bp ladder, lane 14-21: amplified with V8.2-J2.7 primer, lane 11 and 22: 
negative control.   
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2.1.10 TA Cloning 
 
A deoxyadenosine (A) was introduced to the 3’ ends of the purified DNA 
fragments.  Briefly, gel purified PCR products were mixed with dATP, 25mM MgCl2 and 
Taq polymerase (Promega), and incubate at 72°C for 10min.  The products are then 
mixed with salt solution and pCR2.1 - TOPO vector (Invitrogen) and incubated at RT for 
5 minutes.  2μl of the TOPO cloning reaction was added into a vial of One Shot 
Chemically Competent E. coli and mixed gently.  After a 30 minute incubation on ice, the 
cells were heat shocked for 30 seconds at 42°C without shaking.  450μl of pre-warmed 
S.O.C medium were added to the cells.  The tube was shaken (225rpm) at 37°C for 1 
hour.  30-60μl medium from each transformation was spread on LB plate containing 
carbenicillin (1µg/ml). The plates were incubated overnight at 37°C. 
 
 
2.1.11 Plasmid Isolation 
 
About 50 clones per PCR reaction were picked from antibiotic selection plates 
described above.  They were each inoculated to 1ml LB medium containing carbenicillin 
(1µg/ml) and incubated overnight at 37°C with vigorous shaking (250rpm).  The bacterial 
cells were harvested, and cDNA-containing plasmid was purified with the Wizard SV 96 
Plasmid DNA Purification System (Promega), according to the manufacture’s protocol.  
Plasmid DNA was eluted in 100μl nuclease-free water and stored at 4°C. 
 
 
2.1.12 CDR3 Sequencing and Analysis 
 
The cloned PCR products were sequenced using a T7 priming site in the cloning 
vector (T7, 5’-TAATACGACTCACTATAGGG).  Capillary sequencing was performed  
by the St.Jude Hartwell Center for Biotechnology.  V, J and CDR3 nucleotide and 
amino acid sequences were identified with IMGT-V-Quest software (immunogenetics 
information system; http://imgt.cines.fr/). CDR3 charge and hydrophilicity analyses were 
performed with the innovagen peptide calculator (http://www.innovagen.se/). 
 
 
2.2 MOG-specificity of Transduced 4G4 Hybridomas 
 
 
2.2.1 Vector Construction 
 
The orginial XhoI site of 1MOG244.2 MSCV-IRES-CFP vector (Alli et al., 
2008) was deleted by DNA Polymerase I large (Klenow) fragment (Promega).  A new 
XhoI and BamHI sites were created flanking the CDR3 region without altering amino 
acid sequence with the Quick change site directed mutagenesis kit (Stratagene)  
(Figure 2-3).  To generate selected Treg and Tconv TCR constructs, the CDR3 region 
identified during repertoire analyses was PCR amplified with primers incorporating an 
endogenous V8.2 BamHI site and inserting a XhoI restriction site within the C  
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Figure 2-3. Structure of modified retroviral constructs containing new BamHI and 
XhoI sites.  CDR3 region was PCR amplified with primer containing BamHI and XhoI 
sites, and subcloned into the MSCV-I-CFP retroviral vectors. 
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(5’ primer: GGTGCTGGATCCACTGAGAAAGGAGATATCCC 3’ primer: 
GCCTCGAGAACCGTGAGCCTGGTGC).  The PCR products (~200bp) were purified 
with PCR purification kit (Qiagen), and subcloned into the modified 1MOG244.2TCR 
MSCV-IRES-CFP construct, using quick T4 DNA ligase (NEB).  The ligation products 
were chemically transformed into DH5TM E. coli.  60-100µl transformation products 
were spread on LB agar plates containing carbenicillin.  Plates were incubated at 37°C 
overnight.  ~30 clones per construct were selected and plasmid was isolated.  Construct 
integrity was verified by DNA sequencing using a V8.2 primer (Vβ8.2, 5’- 
ATGTCTAACACTGCCTTCCCTGACCC).   
 
 
2.2.2 Transformation of CD4-4G4 T-cell Hybridoma 
 
Ten micrograms of the TCR construct and 10µg of retrovirus helper DNA 
constructs were co-transfected into 293T-cells by calcium phosphate precipitation.  At 16 
h, the cells were washed and cultured in DMEM with 10% FCS, 100U/ml penicillin G, 
100µg/ml streptomycin, 292µg/ml L-glutamine (Invitrogen Life Technologies) for 48 h. 
Supernatant was collected twice daily and used to infect GP+E86 retroviral producer cells 
in the presence of 6 µg/ml polybrene (hexadimethrine bromide; Sigma-Aldrich).  
Transduced GP+E86 cells were expanded in culture, and supernatant was used to infect 
murine surface TCR-deficient 4G4.CD4 T hybridoma cells (gift of Dr.Janeway, Yale 
University, New Haven, CT). 
 
Murine surface TCR-deficient 4G4 hybridoma cells were first transduced with 
mouse CD4-expressing retrovirus (MSCV-CD4-I-GFP), to produce 4G4.CD4 cells (Alli 
et al., 2008; Udyavar et al., 2009).  To transduce the different TCR constructs, 106 
4G4.CD4 cells were harvested and resuspended in 6-10ml retroviral supernatant.  The 
cell suspension was centrifuged at 1800rpm, 8°C for 90 minutes, in the presence of  
6µg/ml polybrene.  The infected cells were then cultured in complete Click's medium.  
The transduced cells were flow cytometrically sorted twice for the GFPhighTCR+ 
population and expanded.  The purity of the GFPhighTCR+ 4G4 cells was confirmed by 
flow cytometry (BD FACSCalibur). 
 
 
2.2.3 Cytokine (IL-2) Analysis by Enzyme-linked Immunosorbent Assay (ELISA) 
 
Cytokine sandwich ELISA is sensitive enzyme immunoassay that can specifically 
detect and quantitate the concentration of soluble cytokine proteins.  The transduced 
4G4.CD4 cells (1x105) were cultured in the presence of 3x105 APCs.  In one experiment, 
they were stimulated with 10-fold titrations of MOG35-55 (100µg/ml, 10µg/ml, 1µg/ml, 
0.1µg/ml and 0µg/ml).  In the other experiment, cells were cultured with 100µg/ml 
MOG35-55 or the indicated alanine-substituted peptides.  100μl of supernatant was 
collected from the cultures 24 hours after stimulation.  To measure the IL-2 concentration, 
purified anti-IL-2 capture antibody (clone MQ1-17H12) was diluted to 2µg/ml in binding 
solution.  50µl of the diluted antibody was added per well of a 96-well ELISA plate 
(Nunc Maxisorb) and incubated at 4°C overnight.  Capture antibody was then removed, 
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and non-specific binding was blocked by adding 200µl of blocking buffer per well (BD 
Bioscience), and incubated at RT for 2hrs.  After wash with PBS/Tween (PBS and 0.1% 
Tweens) for 3 times, culture supernatants were added to the coated plate, 100µl per well.  
A series of nine two-fold dilutions of recombination mouse IL-2 standard (from 
5000pg/ml to 19.5pg/ml) was added to same wells.  The plate was incubated at 4°C 
overnight.  After washing away unbound material with PBS/Tweens, 100µl diluted 
biotinylated anti-IL-2 (1µg/ml) was added and incubated room temperature for one hour.  
Again after washing with PBS/Tween for five times, 100µl diluted peroxidase labeled 
anti-biotin (Vector laboratories, Burlingame, CA) was added and incubated for 30 
minutes.  The plate was washed for eight times and ABTS substrate solution with 
hydrogen peroxide was added.  After color developed, the OD was read by a microplate 
reader (Bio-Rad) setting to 405nm. 
 
 
2.3 Generation of TCR-retrogenic Mixed Chimeras 
 
Retroviral constructs incorporating the TCR from MOG-specific TCRs were 
generated and transduced into GP+E86 producer cells as described above.  These 
transduced producer cells were used to infect HPCs from B6.129S7-Rag1tm1Mom /J.  The 
transduction efficiency was evaluated by flow cytometry for CFP.  The HPCs were mixed 
at a 1:1 or 1:10 ratio with untransduced, T-cell depleted CD45.1 congenic B6.SJL-
PtprcaPep3b.BoyJ-derived bone marrow, and injected i.v into lethally irradiated (1100Rad) 
B6.SJL-PtprcaPep3b.BoyJ mice.   
 
 
2.4 Flow Cytometric Analysis of TCR-retrogenic Mixed Chimeras 
 
Eight weeks after transplantation, splenocytes and thymocytes were isolated.  
Entire splenocytes were stained with a mix of antibodies specific for CD4 (clone L3T4), 
TCR (clone H57-597) and CD45.2 (clone 104).  Entire thymocytes were stained with the 
mix of antibodies specific for CD4, CD8, and CD45.2.  After washing, the cells were 
fixed and permeabilized by 1ml Fixation/Permeabilization working solution for 30 
minutes (eBioscience).  Cells were then stained with PE conjugated anti-Foxp3 (clone 
FJK-16s, eBioscience), and analyzed by flow cytometry. 
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CHAPTER 3.  GENERATION OF 1MOG244.2TCR RETROGENIC MICE 
 
 
3.1 Introduction 
 
Immune homeostasis is maintained partially by Treg cells that dominantly control 
potential hazardous self-reactive T-cells in the periphery.  Their suppressive features and 
direct inhibition of autoimmune diseases attracted a decade of active investigation into 
their biology.  TCR repertoire analyses shed light on the origin of Treg and their 
relationship with Tconv cells.  This chapter describes the development of a mouse model 
that is not only susceptible for EAE but also facilitated the performance of Treg 
repertoire analysis.   
 
The diversity of the mature T-cell repertoire is generated by the rearrangement of 
various gene segments and addition of nucleotides not present in germline to form the  
and  chain of the TCR, and the random paring of  and  chains.  In theory, more than 
1015 different possible  TCR may form in mice (Davis and Bjorkman, 1988).  But in 
reality, most (about 95%) of thymocytes die during the development processes as they 
fail either positive or negative selection.  Only 5% survive to become mature T-cells.  
Casrouge et al. has estimated that the actual mouse naïve T-splenocytes repertoire 
contains 2x106 unique clones by the immunoscope technique.  This figure, although 
orders of magnitude smaller than the maximum theoretical diversity (1015), is still large 
enough to maintain a high functional level of diversity (Casrouge et al., 2000).   
 
The ideal way to analyze TCR repertoire would be identify both  and  chains of 
each T-cell.  However, technical limitations make it impractical to perform this on a large 
scale.  Most current TCR repertoire analyses rely on the use of transgenic mice in which 
one chain of the TCR is fixed (Hsieh et al., 2004; Malherbe et al., 2004; Wong et al., 
2007b; Zehn and Bevan, 2006).  The fixed  or  chain limits the repertoire variation to 
the alternative chain.  This technique not only simplifies the complicated system, but also, 
if the fixed chain has a propensity for auto-reactivity, will result in larger than normal 
populations of self-reactive cells, thereby facilitating analyses of the self-reactive 
repertoire.  We used lethally irradiated mice reconstituted with bone marrow progenitor 
cells transduced with a retrovirus incorporating a rearranged TCR chain, so called 
retrogenic mice (Holst et al., 2006a).  The advantages of the retrogenic system are rapid 
development (2months) and that they allow analysis of mice expressing different 
TCRsimultaneously.  The major alternative TCR transgenic mice are more costly and 
time consuming to create, and surveying multiple TCR would be difficult.  On the other 
hand, fewer T-cells develop in retrogenic mice than transgenic mice and they cannot 
propagate by breeding.  Here we developed a retrogenic model of MOG-EAE in which 
the TCR chain locus is fixed by the enforced retrogenic expression of a TCR from a 
MOG-specific T-cell.   
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3.2 Results 
 
 
3.2.1 Retrogenic Mice Expressing a Single TCR V Chain 
 
To generate a retrogenic mouse model susceptible to EAE, we first generated 
several different strains of retrogenic mice, each incorporating a different  chain.  
Briefly, we bred Cα KO mice (Mombaerts et al., 1993) with GFP-FoxP3 KI mice 
(Fontenot et al., 2005b), and transduced the bone marrow of the offspring with retroviral 
constructs incorporating the α chain from 1MOG244.2, 2MOG10, 1MOG9, and 
1MOG213 MOG-specific TCRs.  Cα KO mice do not express any α chain.  That ensures 
the bone marrow cells only contain the rearranged transduced α chain.  Because Cα KO 
mice have normal RAG-recombinase and an intact TCR of  genome, the complete 
genome of β chains, the engrafted bone marrow progenitor cells will complete β chain 
rearrangement from genomic V, D, J segments and develop into T-cells with a diverse 
repertoire.  In addition, the GFP-FoxP3 transgene allows the rapid identification of 
regulatory T-cells (CD4+GFP+) and conventional T-cells (CD4+GFP-) by GFP 
florescence.   
 
6 weeks post hematopoietic progenitor cell (HPC) transplantation, the peripheral 
blood were collected and stained with antibodies specific for CD4 and TCR.  
Engraftment was verified by assessing for the presence of CD4+TCR+ in gated 
lymphocytes, and this ranged from 1% to 5%.  Mice were challenged with MOG35-55 
peptide in CFA, as described in Chapter 2.  The retrogenic mice bearing the different 
specific TCR α chains show inducible EAE, but the severity of disease was strongly 
influenced by the introduced α chain.  Only 1MOG244.2 retrogenic mice developed 
EAE with high penetrance in response to MOG35-55 immunization, with >90% of mice 
developing typical disease symptoms (Figure 3-1B).  Mice expressing other TCR 
developed more mild disease (Figure 3-1A).  Hence, we chose 1MOG244.2TCRα 
retrogenic mice as a mouse model to further evaluate the TCR repertoire. 
 
 
3.2.2 Phenotype of 1MOG244.2TCRRetrogenic Mice 
 
At approximately eight weeks post-HPC transfer, the retrogenic mice showed 
good lymphoid engraftment.  Thymocyte subsets showed no significant difference in 
absolute cell number, percent of DN, DP, CD4+ SP and CD8+ SP subsets compared with 
C57BL/6 mice, though they trended toward increased double negative (DN) cells (7.0% ± 
6.8% 1MOG244.2 versus 3.0% ± 1.3% C57BL/6) and decreased CD4+ SP cells (1.7% ± 
1.8% versus 7.0% ± 3.8%) (Figure 3-2A).  Specific analyses of DN3 and DN4 cells 
subpopulation revealed no statistical difference between retrogenic mice and C57BL/6 
mice  Retrogenic mice showed a slightly decreased percent of DN4 subsets among total 
DN cells (47.93% ± 5.868% 1MOG244.2 versus 55.33% ± 6.886% C57BL/6) (Figure 
3-2B-D), though not statistically significant.  The DN4 population identified in retrogenic 
mice demonstrated that a substantial number of DN3 cells pass through -selection 
checkpoint while expressing the retrogenic TCR chain.  This is significant as some  
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Figure 3-1. EAE induction in retrogenic mice.  (A) 1MOG244.2, 2MOG10, 1MOG9, 
and 1MOG213 TCR retrogenic and wild-type mice (n=4 or 5) were immunized with 
MOG35-55.  EAE was clinically monitored.  Mean clinical score is plotted.  (B) EAE was 
induced on 1MOG244.2 mice (n=10).  Ten of 10 mice developed disease symtoms with 
a mean ±1 s.d. maximal score of 2.6 ± 1.4 (range 1-5).  Plot shows mean clinical score ± 
1 s.e.m. 
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Figure 3-2. Thymocyte reconstitution in retrogenic mice.  1MOG244.2α retrogenic 
mice were sacrificed ~8 weeks after HPC transfer, and thymocytes were isolated and 
quantitatively analyzed for the indicated cell subsets.  (A) Percent of DN, DP, or CD4+ or 
CD8+ SP T-cells among 1MOG244.2α or simultaneously analyzed C57BL/6 thymocytes 
is shown.  (B) Percent of DN3 or DN4 cells among CD4-CD8-TCR- thymocytes.  (C and 
D) Flow cytometric analysis shows DN3 and DN4 cells development in the CD4-CD8-
TCR- gated populations. 
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reports have shown a decreased DN3 to DN4 transition in TCR transgenic mice 
(Baldwin et al., 2005; Borowski et al., 2004; Huang and Kanagawa, 2004; Lacorazza et 
al., 2001).   
 
Analyses of the periphery showed a mean of 83 ± 6 x106 total splenocytes in 
retrogenic mice, primarily B-cells (Figure 3-3C).  Engrafted T-lymphocytes were 
decreased compared to wild-type C57BL/6 mice (data available at www.jax.org), and 
comprised 13.8 ± 4.9% of lymphocytes in the spleen and 9.7 ± 2.9% in the lymph nodes 
(LN) (Figure 3-3A and B).  The CD4/CD8 ratio was elevated, 6.2 ± 1.3 in the lymph 
nodes (LN) and 10.0 ± 2.7 in the spleen compared with ~1.6 in C57BL/6 mice (Figure   
3-3D), indicating that the 1MOG244.2TCR developmentally skewed cells to the CD4 
lineage.  CD4+ T-cells expressed the GFP-Foxp3 transgene in proportions comparable to 
that observed in wild-type mouse strains, 12.8 ± 2.2% in LN and 7.5 ± 2.4% in spleen 
(Figure 3-3A and B).  Therefore mice expressing the 1MOG244.2 transgene develop a 
repertoire that incorporates normal proportions of CD4+ Treg and Tconv cells and they 
are susceptible to EAE, though showing decreased representation of CD8+ T-cells.  
 
 
3.2.3 V Use in 1MOG244.2TCR Splenic T-lymphocytes 
 
We first analyzed peripheral TCR repertoire in unimmunized 1MOG244.2α mice 
by examining Vβ chain usage by monoclonal antibody (MAbs) staining (Figure 3-4).  
These mice, with a fixed Vα5-Jα43 chain, showed different Vβ use compared with wild-
type C57BL/6 mice.  A substantially increased usage of Vβ14 was seen, 15.2% ± 4.1% in 
retrogenic mice versus 6.49% ± 0.48% in wild-type (p = 0.0128).  Significantly fewer 
Vβ3 (p = 0.0018), Vβ4 (p = 0.0348), and Vβ8.3 (p = 0.003) T-cells were seen, potentially 
due to the compensation for the increased Vβ14 use.  However, Vβ8.1/8.2 was the most 
frequently used TCR among retrogenic mice, and wild-type mice showed a similar 
percentage.   
 
 
3.2.4 Increased TCR Vβ8.2 Use in CNS-infiltrating 1MOG244.2 T-cells 
 
As a low resolution screen for EAE-associated alterations in the 1MOG244.2 
TCR repertoire, we analyzed Vβ chain use by staining splenic or CNS CD4+ GFP-Foxp3- 
and GFP-Foxp3+ cells with Vβ-specific Abs.  A significant increase in Vβ8.1/8.2+ use in 
CNS-infiltrating Tconv was seen (p = 0.018) compared with paired splenic Tconv or 
Tconv from unimmunized controls (Figure 3-5A).  This is consistent with the 
documented over-representation of this receptor among MOG35-55/Ab-specific Teff cells 
(Mendel et al., 1995; Mendel Kerlero de Rosbo and Ben-Nun, 1996).  A trend toward 
increasing Vβ8.1/8.2 TCR use was also seen among CNS Treg (Figure 3-5B), though this 
did not achieve statistical significance.  A decrease in V8.3 TCR among Treg cells (p = 
0.048) was also seen, possibly due to compensation for the increased V8.1/8.2 usage.  
Therefore 1MOG244.2 mice express a TCR repertoire that is modified by EAE 
induction.  Further, Vβ8.1/8.2-expressing T-cells are concentrated in the CNS during 
EAE, implying increased MOG-reactivity in the infiltrating T-cell population.   
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Figure 3-3. Lymphoid reconstitution of retrogenic mice.  1MOG244.2α retrogenic 
mice were sacrificed ~8 weeks after HPC transfer.  Spleen and LN cells were isolated and 
quantitatively analyzed for the indicated cell subsets.  Percent LN (A) and splenic (B) 
reconstitution with total T-lymphocytes (TCR+) and CD4+ T-lymphocytes (CD4+TCR+), 
and fractional engraftment with CD4+TCR+ GFP-Foxp3+ T-lymphocytes 
(Foxp3+/CD4+TCR+) are plotted for individual mice.  Means are indicated by the 
horizontal bar.  The remaining lymphocytes were composed predominantly of B-cells.  
(C) Absolute number of total splenocytes and TCR+ splenocytes is plotted.  (D) The ratio 
of CD4+/CD8+ T-cells is plotted. 
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Figure 3-4. V use by splenic Tconv in 1MOG244.2 and C57BL/6 mice.  8 weeks 
post transfer of HPCs, 1MOG244.2 (n = 5) were sacrificed and CD4+ T-cells were flow 
cytometrically analyzed using a panel of V-specific antibodies.  C57BL/6 mice (n = 4) 
were analyzed simultaneously.  Significant differences between wild-type and retrogenic 
mice were seen.  *, p < 0.05.   
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Figure 3-5. V use by retrogenic Treg and Tconv in pre-immune splenocytes and 
splenocytes and CNS-infiltrating cells from mice with EAE.  Preimmune retrogenic 
mice or mice 17 days after EAE induction were sacrificed and CD4+ T-lymphocytes flow 
cytometrically analyzed using a panel of V-specific antibodies.  Comparisons were 
made between Tconv (A) and Treg (B) cells from unimmunized and immunized 
splenocytes and CNS T-cells from mice with EAE.  Data show mean + 1 SEM.  *, p < 
0.05 among group by Hochberg-adjusted 1-way ANOVA. 
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3.3 Summary 
 
TCR repertoire analysis has been used to determine the origins of Treg and their 
relationship with Tconv cells.  This type of study is difficult to perform directly on the 
naive repertoire due to its high diversity.  To circumvent this problem, we developed 
retrogenic mice expressing a retrovirally transfected TCR chain.  Briefly,  chain 
isolated from MOG-specific TCR was subcloned into MSCV-IRES-CFP vector.  Bone 
marrow stem cells from Tcr-/- GFP-Foxp3 mice were retrovirally transfected with  
chain, and then transplanted into irradiated Tcr-/- mice.  Several different TCR 
retrogenic mice were generated and challenged with MOG35-55 in CFA.  1MOG244.2 
mice showed similar disease severity as C57BL/6 mice, though the mice experienced 
later disease onset than wild-type mice.   
 
Analyses of 1MOG244.2 thymocytes revealed no significant differences 
compared with C57BL/6 mice.  The DN to DP transition was efficient, and the percent of 
DN3 and DN4 among DN population did not show significant differences to wild-type 
mice.  This suggests that the premature TCR expression which in some models leads to 
diminish pT signaling does not alter the balance of different thymocyte subsets in 
1MOG244.2 mice.  Further analyses of peripheral lymphocytes showed a decreased 
percent of T-cells, which potentially reflects the effects of transplantation into the   
TCR-/- mice.  The ratio of CD4/CD8 is elevated five-fold versus wily type splenocytes.  
This suggests that the enforced  chain expression impacts the peripheral repertoire to 
some extent, favoring the CD4+ lineage commitment or expansion.  More importantly, 
the proportion of Treg cells among CD4+ T-cells is normal.  Treg lineage assignment in 
1MOG244.2 mice does not appear to be altered by the fixed  chain.   
 
V usage analysis was performed on unimmunized retrogenic and C57BL/6 mice.  
V8.1/8.2 was the most frequently used TCR in both of these.  However, the percent of 
V14 cells was substantially increased in retrogenic mice, suggesting that the enforced  
chain did influence on V selection.  After EAE induction, T-cells bearing V8.1/8.2 
accumulate in CNS in C57BL/6 mice, and this was similarly seen in the retrogenic mice.  
Overall, although some difference exist between wild-type and 1MOG244.2TCR 
retrogenic mice, this mouse does appear suitable for the analysis of repertoires in EAE. 
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CHAPTER 4.  TCR REPERTOIRE ANALYSIS OF 1MOG244.2TCR 
RETROGENIC MICE 
 
 
4.1 Introduction 
 
Treg cells can be produced in the thymus as a functionally mature, distinct T-cell 
population.  Sakakura first showed that neonatal thymectomy of female mice at 3 days of 
age led to autoimmune oophoritis and sterility (Nishizuka and Sakakura, 1969).  
Subsequent studies showed that other organs could be affected depending on the genetic 
background of the inbred mouse strain.  Disease could be prevented either by thymus 
engraftment or by transfer of normal day 7 or adult spleen cells (Kojima et al., 1980; 
Kojima et al., 1976).  Efforts to search for more specific markers for Treg identified the 
CD25 molecule (the IL-2 receptor  chain) as a candidate (Sakaguchi et al., 1995).  
Subsequently, the transcription factor Foxp3 was shown to be critical for Treg 
differentiation in thymus (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003).  
Over-expression of Foxp3 on naïve human CD4+ T-cells confers suppressor function 
(Oswald-Richter et al., 2004; Yagi et al., 2004), and ectopic expression of a transgene 
encoding Foxp3 in mice (Khattri et al., 2003) or retroviral expression of Foxp3 in CD25-
CD4+ T-cells results in the acquisition of suppression activity (Fontenot et al., 2003; Hori 
et al., 2003).  Conversely, genetic disruption of Foxp3 in humans and mice leads to 
autoimmune disease.  Foxp3 is currently the most reliable molecular marker for natural 
Tregs and provides clues to decipher the molecular basis of Treg development and 
function.  Furthermore, studies showing the CD4+CD25+ T-cells from MHC class II 
deficient mice do not suppress responder T-cells in vitro or in vivo, suggested that the 
development of Treg cells is dependent on MHC class II-positive thymic cortical 
epithelium (Bensinger et al., 2001).   
 
Despite advances in our understanding of Treg development and function, we still 
do not know how these cells are generated and the role of TCR specificity in diverting 
thymocytes into the conventional or regulatory lineage.  Sequence analyses of TCR 
segments of a particular V subfamily in Treg cells from TCR-fixed transgenic mice 
have revealed strong similarity between the thymic and peripheral Treg TCR repertoire 
(Hsieh et al., 2006; Pacholczyk et al., 2006; Wong et al., 2007b), echoing the view that 
Treg cells are mainly generated in the thymus (Itoh et al., 1999).  However, the 
peripheral and thymic Treg TCR repertoires were not identical, suggesting that certain 
TCRs are preferentially enriched or deleted in the periphery, similar to the observations 
with the total CD4+ T-cell population (Correia-Neves et al., 2001).  Further analyses of 
the TCR sequences from fractionated Treg or Tconv cells demonstrated distinct 
repertoires of the two populations, although with a degree of overlap that differed 
depending on the experimental setting.  These studies were performed with unimmunized 
adult mice, and the relationship between the two subsets in mice with autoimmune 
disease like EAE circumstance was still unclear.  To clarify the TCR repertoire 
differences between Treg and Tconv cells in MOG-EAE, we examined J usage and the 
CDR3 sequence of Treg and Tconv cells from 1MOG244.2 mice with or without EAE. 
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4.2 Results 
 
 
4.2.1 TCR J and CDR3 Use in MOG-EAE 
 
To examine alterations in the Treg and Tconv repertoires at higher resolution, we 
sacrificed 1MOG244.2 mice prior to immunization or 23-25 days after EAE induction.  
Spleen and, for mice with EAE, CNS cells were collected and pooled from 5-6 identically 
treated mice per group.  Pooling was performed due to low post-isolation T-cell yields 
from the CNS of retrogenic mice.  The cells were sorted based on CD4 and the presence 
or absence of GFP-Foxp3 expression.  RT-PCR was performed to analyze the paired β 
chains in each organ and cell type.  V8.2-C or V8.2-J2.7 primers were used to 
amplify TCR cDNA.  We established a robust system to PCR amplify TCRβ cDNA 
without contamination, and the same experiment was repeated twice.  Five PCR reactions 
were performed on each cDNA to avoid PCR bias.  The 400 bp DNA segments were TA 
cloned into pCR2.1 vector, 50-100 clones were picked and sequenced the with T7 primer.  
Finally, we submitted the sequences in bulk to the IMGT (immunogenetics information 
system; http://imgt.cines.fr/) web server for identifying the TCR gene use.  Totally ~4000 
sequences were collected.  The identical experiment was performed twice.   
 
We initially surveyed V8.2-C sequences to determine the distribution of J 
among V8.2+ TCR.  In total, 1829 sequences were assessed.  Twelve different J 
regions were found in these TCR sequences.  J used by Treg and Tconv cells showed no 
significant difference in either spleen or CNS (Figure 4-1C and D).  This hinted that Treg 
cells have a diverse V8.2+ TCR repertoire as Tconv cells, and this diversity was not 
altered by autoimmunity circumstances.  Proportions of J used by either the Foxp3+ or 
Foxp3- populations showed no significant differences between the CNS and periphery in 
mice with EAE (p > 0.05, Figure 4-1A and B).  Comparison of pre- and post-immune 
splenocytes also failed to identify changes in J use among Foxp3+ T-cells and showed a 
significant difference in Foxp3- cells only for a single J, J2.4 (6.2 ± 0.5% pre versus 
14.1 ± 0.5% post; p = 0.012).  This indicates preserved diversity in the V8.2+ population 
with EAE induction, especially when comparing the CNS-infiltrating and splenic T-cell 
populations of diseased mice.   
 
We next surveyed the more circumscribed V8.2-J2.7 repertoire.  V8.2was 
selected due to the predominate expression of V8.2 among MOG-specific T-cells in H-
2b mice (Mendel Kerlero de Rosbo and Ben-Nun, 1996) and J2.7 due to its use in the 
original V8.2+J2.7+ TCR chain partner for the 1MOG244.2 TCR (Alli et al., 2008).  
Despite the theoretical potential for formation of >106 unique TCR sequences with this 
V-J constraint, we therefore knew that V8.2+J2.7+ TCR had the potential to pair 
with the 1MOG244.2 to form MOG-specific TCR.  An estimated 95% confidence 
interval for the upper limit of the maximum frequency (φmax) of unobserved TCR CDR3 
sequences for individual cell types/samples in different experiments ranged from 1.4 to 
3.1% for different samples and cell types (Table 4-1).  The φmax confidence interval (CI) 
refers to the upper frequency of a CDR3 sequence in the V-J analysis for which there is  
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Figure 4-1. J used in Tconv and Treg cells.  CD4+ T-cells from retrogenic mice, 
preimmune or EAE induction, were flow cytometrically sorted into CD4+Foxp3- and 
CD4+Foxp3+ populations.  After a few steps of RT-PCR, TA clone and sequencing, 
CDR3b regions were identified through IMGT.  Comparisons were made between Tconv 
(A) and Treg (B) cells from unimmunized and immunized splenocytes and CNS T-cells 
from mice with EAE.  Comparisons were also made between Tconv and Treg cells in 
immunized CNS T-cells (C) and in immunized splenocytes (D).  * P < 0.05. 
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Table 4-1. Isolation of TCR V sequences from retrogenic mice. 
 
Experiment Disease scores T-cell type Sequence 
Isolated 
sequences V-J max 
95% CI V-C V-J 
1 (Pre-
immune) NA Spleen Foxp3- 
Total 137 155  
  Unique 131 55 2.25% 
  Spleen Foxp3+ Total 152 183  
  Unique 150 64 1.91% 
       
2 (Pre-
immune) NA Spleen Foxp3- 
Total 102 161   
  Unique 97 54 2.17% 
  Spleen Foxp3+ Total 128 123  
  Unique 124 62 2.85% 
       
3 (EAE, Day 
23) 
1,2,3,3,
4 Spleen Foxp3- 
Total 159 167   
  Unique 97 52 2.09% 
  Spleen Foxp3+ Total 131 141  
  Unique 57 46 2.48% 
       
  
CNS Foxp3- 
Total 207 256  
  Unique 90 42 1.36% 
  CNS Foxp3+ Total 147 226  
  Unique 88 59 1.54% 
       
4 (EAE, Day 
25) 
1,1,1,2,
2,2 Spleen Foxp3- 
Total 160 208   
  Unique 71 48 1.68% 
  Spleen Foxp3+ Total 144 114  
  Unique 82 49 3.08% 
       
  
CNS Foxp3- 
Total 207 211  
  Unique 82 45 1.65% 
  CNS Foxp3+ Total 155 207  
  Unique 60 41 1.68% 
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95% certainty of positive detection.  For example, there were a total of 155 amino 
sequences in splenocyte Treg of pre-immune sample in experiment 1, if the frequency of 
particular CDR3 sequence in the population is above 2.25%, the chance for it to be 
detected is 95%.  This indicates that the collected sequences were adequate to survey 
common sequences in each cellular cohort.   
 
Among the V8.2-J2.7 sequences obtained, 452 unique amino acid sequences 
were identified.  Interestingly, 54 (~12%) of sequences were shared, or public sequences, 
among the 4 independent experiments.  Public sequences were over-represented among 
more commonly identified sequences, with 74% of public sequences present within the 
100 most frequent sequences.  An increased probability of identifying sequences in 
multiple independent samples when their sequence frequency is high is expected, and 
implies that the observed proportion of public sequences underestimates total 
representation due to non-identification of low frequency public sequences.  16/54 public 
sequences were found in TCR exclusively used by Treg, 14/54 in Tconv TCR, and 24/54 
in sequences identified both in Treg and Tconv.  The CDR3 amino acid sequences of 
public sequences were diverse and no sequence patterns were identified.   
 
Abundance coverage estimator analysis (ACE) of pooled sequences, an indicator 
of total sequence diversity, indicated a limited diversity consistent with findings in other 
systems, with values of 271 and 337 for pre-immune, and 191 and 171 for post-immune 
V8.2+, J2.7+ Tconv and Treg splenocytes respectively.  This restricted diversity and 
the high proportion of public sequences indicates that the retrogenic repertoire is heavily 
sculpted and that few of the potential sequences that may form from V-D-J 
rearrangement are realized in the retrogenic mice.  Interestingly, the original  chain  
partner for the 1MOG244.2 TCR (ASGDAGTGYEQY) was among the public 
sequences identified in the CNS Foxp3- populations of both EAE induction experiments, 
though not in pre-immune analyses.  This suggests that receptors relevant to EAE in 
C57BL/6 mice, which served as the source of the 1MOG244.2 hybridoma, play a role in 
the 1MOG244.2 retrogenic mice.   
 
Among public TCR, 20 CDR3 sequences were identified as common to both 
preimmune T-cells and T-cells from mice with EAE.  TCR sequences appearing 
predominantly in Foxp3+ or Foxp3- populations preimmune showed the same orientation, 
Foxp3+ or Foxp3-, in mice with EAE for 19 of the 20 receptors.  This implies that TCR 
sequence rather than disease status is the primary force governing T-cell Foxp3 
expression. 
 
 
4.2.2 Limited Overlap of Treg and Tconv Repertoires 
 
Comparison of unique CDR3 amino acid sequences for each cellular cohort 
revealed several notable features.  Repertoire overlap was greater among a single class of 
cells (Treg or Tconv) across different organs (spleen and CNS) than among different 
classes of cells within an organ (Figure 4-2A).  In experiment 3, 32.7% of unique splenic 
and CNS Treg sequences and 23.9% of unique splenic and CNS Tconv sequences  
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Figure 4-2. Population differences among TCR subsets in mice with EAE.  (A) 
Unique TCR sequences from the identified experiments (Table 4-1) were compared 
between population groups, and the frequency of sequences shared by Treg and Tconv 
cells within an organ (left) or of sequences from a specific cell type, Treg and Tconv cells, 
shared across organs (right) plotted.  (B) The Morisita-Horn index, a measure of ecologic 
diversity among populations, is plotted for the same groups as (A). A value of 1.0 
indicates population identity. Whereas (A) plots sharing of uniquely identified sequences, 
(B) measures differences in both sequence diversity and identification frequency between 
the indicated populations. 
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overlapped.  In contrast, only 11.0% of unique CNS and 10.1% of unique splenic were 
shared between Treg and Tconv cells.  In experiment 4, the values were 20.0%, 27.4% 
14.7%, and 6.6%, respectively.  In addition, we used the Morisita Horn index to estimate 
similarity between populations.  The Morisita Horn index is a commonly used, unitless 
quantitative index of the similarity between two populations (a value of 1.0 represents 
complete identity) that uses information regarding the number of species as well as the 
abundance of each species.  The Morisita Horn index was widely used in T-cell repertoire 
studies before (Hsieh et al., 2006; Pacholczyk et al., 2002).  Here, the M-H index also 
demonstrated strong dissimilarity in Treg and Tconv cell CDR3 sequences in either 
spleen or CNS and greater similarity when an individual cell type was compared between 
spleen and CNS (Figure 4-2B).  Taken together, Treg and Tconv TCR repertoires are 
distinct, though do show some overlap. 
 
To determine whether disease has an impact on the degree of overlap, we also 
compared the repertoires of preimmune and EAE mice.  In preimmune experiment 1 and 
2, the percent of unique shared TCRs between splenic Treg and Tconv cells was 3.5% 
and 6.4% respectively.  In EAE experiment 3 and 4, the overlap was 10.1% and 6.6% in 
spleen, and 11.0% and 14.7% in CNS.  Therefore there is a trend toward increasing 
overlap with disease development.  However, this did not achieve statistical significance, 
(p = 0.28 for preimmune versus EAE spleen, and p = 0.22 for EAE spleen versus EAE 
CNS).  This implies that autoimmune disease has limited impact on the overlap of Treg 
and Tconv TCR repertoire, and argues against substantial levels of intercoversion during 
autoimmunity. 
 
Further, among the minority of unique sequences that were shared by Treg and 
Tconv cells, the isolates of a particular sequence were typically skewed toward a single 
class of cells, either Treg or Tconv cells.  Indeed, the Treg/Tconv cell identification ratio 
of shared TCR should form a Gaussian distribution, potentially around a ratio of 1, if 
there was rapid, free and equal interconversion between Treg and Tconv cells. Yet 73% 
of shared CDR3 isolates were skewed by a ratio ≥2:1 toward a single cell class (Figure  
4-3A), mean and median for majority Foxp3+ TCR: 6.1 ± 7.3, 2.5; Foxp3− TCR: 9.1 ± 
11.4, 5.1).  This was influenced by the presence of CDR3 for which few sequences were 
isolated, and for which substantial skewing would therefore not be possible. Indeed, for 
shared sequences independently identified at least 10 times, 84% had a ratio ≥2:1 (Figure 
4-3B; mean, median for Foxp3+: 9.3 ± 8.4, 9.1; Foxp3−: 13.4 ± 13.8, 10.0).  Skewing of 
CDR3 toward a single cell class, Treg or Tconv cells, was also readily apparent in 
graphical mapping of the distribution among Foxp3+ or Foxp3− cells of the most common 
sequences isolated in individual experiments (Figure 4-4 and 4-5).   
 
Comparative analyses were further performed on three structural features of the 
identified CDR3, length, charge, and hydrophilicity as potential correlates of specificity.  
The six cohorts of unique CDR3 sequences, acquired from postimmune CNS, 
postimmune spleen, and preimmune spleen Foxp3+ and Foxp3− cells were compared via 
the Kruskal-Wallis test and significance was observed only for charge (p < 0.0001).  With 
the Wilcoxon rank-sum test to compare any two cohorts within this group, the charge of 
the CNS Foxp3− CDR3 showed significant differences with each of the five other 
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Figure 4-3. Distribution of shared CDR3 sequences.  Numbers of CDR3 amino acid 
sequences identified in both Foxp3+ and Foxp3- populations at the indicated ratio is 
shown.  Left sides of plots indicate sequences that were primarily identified among 
Foxp3+ cells, and right sides indicate sequences primarily identified among Foxp3- cells. 
A 1:1 ratio indicates equal numbers of sequences were identified among Foxp3+ and 
Foxp3- populations.  (A) Data is plotted for all shared sequences identified.  (B) Data is 
plotted only for those shared sequences identified 10 or more times. 
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Figure 4-4. Frequency representation of the most common splenic V8.2+J2.7+ 
CDR3 isolates.  Frequencies of the 10 most commonly isolated splenic CDR3 sequences 
from GFP-Foxp3+ (A) or GFP-Foxp3- (B) T-cells in each of the 4 experiments is plotted 
(filled bars).  CDR3 frequencies are shown as percent values and were defined as 100 * 
(Foxp3+ or Foxp3- CDR3 isolates with the indicated sequence) / (total number of Foxp3+ 
or Foxp3- splenic CDR3 sequences for the indicated experiment).  Experiments 1 and 2 
assayed preimmune mice, and 3 and 4 studied mice with EAE.  For sequences shared 
among Foxp3+ and Foxp3- populations, below each filled bar the representation of the 
identical sequence in the alternative population is plotted, Foxp3- cells in (A) and Foxp3+ 
cells in (B) (unfilled bars). 
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Figure 4-5. Frequency representation of the most common CNS-derived 
V8.2+J2.7+ CDR3 isolates.  Analyses were performed as in Figure 4-4, but for CNS-
derived sequences from experiments 3 and 4. 
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cohorts (Figure 4-6) (p ≤ 0.02 for all comparisons after Hochberg's adjustment for 
multiple tests).  A significant difference was seen in only one other comparison group, 
CNS and preimmune splenic Foxp3+ CDR3 (p = 0.019).  Therefore, CNS-infiltrating T-
cells, particularly Foxp3− cells, possess at least one distinguishing CDR3 characteristic, 
increased negative charge.  Of note, the MOG35-55 epitope bears a potentially 
complementary positive charge and includes three arginine residues, two of which are 
predicted to lie in the Ag binding groove with their guanidinium moieties directed toward 
the TCR (Ben-Nun et al., 2006).   
 
 
4.3 Summary 
 
We analyzed the Treg and Tconv cell TCR repertoires in EAE utilizing a 
retrogenic mouse model in which the TCR chain locus is fixed.  The overlap between 
Treg and Tconv cells was less than the overlap when a single class of cells was compared 
in two different organs - the spleen and CNS.  This demonstrates that Treg and Tconv 
cells express largely distinct TCRs in the CNS and spleen of mice with EAE.  
Nevertheless, some overlap (~10%) was seen.  This result echoed previous studies 
performed on unimmunized mice, which saw overlap between Treg and Tconv TCR 
repertoires, ranging from 10% to 20% (M-H index of 0.1-0.2) (Hsieh et al., 2004; Hsieh 
et al., 2006; Lathrop et al., 2008; Pacholczyk et al., 2006).   
 
Comparison between preimmune and EAE mice revealed that the degree of 
overlap was not significantly increased in EAE.  Among CDR3 shared by Treg and 
Tconv cells, individual sequences tended to be dominantly represented within a single 
cell type.  These results argue against large scale interconversion in an inflammatory 
environment.  It is consistent with previous results, in which little conversion was found 
after the adoptive transfer of CD4+ CD25- T-cells (Lathrop et al., 2008) and in TCR 
repertoire analysis of NOD mice (Wong et al., 2007a).  In contrast it has also been 
suggested that conversion contributes to ~72% of peripheral Treg cells (Liang et al., 
2005).  
 
Public TCRs were identified in the V8.2-J2.7 repertoire shared in the four 
independent experiments (preimmune and EAE mice).  This is consistent with the 
previous report that T-cells express V and V public repertoires in the CNS of C57BL/6 
mice during MOG-EAE (Fazilleau et al., 2006). Further the original 1MOG244.2TCR 
was among the public sequences identified in the CNS Foxp3- group, implying that this 
particular TCR is important to EAE in retrogenic and C57BL/6 mice.   
 
In summary, these results and the identification of distinct charge characteristics 
specifically among CNS-infiltrating Tconv cells implies that Treg and Tconv cells in 
EAE are distinct populations and do not substantially interconvert. 
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Figure 4-6. Length, charge, and hydrophilicity of isolated CDR3.  Medians ± 95% CI 
for length (A), charge (B), and hydrophilicity (C) among unique CDR3 sequences 
identified in the six indicated populations is plotted.  Analyzed sequences were 
determined as the regions bounded by but not including the conserved C and F residues 
bordering each CDR3β.  *p < 0.05 according to the Hochberg-adjusted Wilcoxon rank 
sum test. 
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CHAPTER 5.  ANALYSIS OF TCR IN 1MOG244.2TCR RETROGENIC MICE  
 
 
5.1 Introduction 
 
T-cell development begins in the thymus, and one of the earliest events is TCR 
gene rearrangment.  The mature thymocyte repertoire is formed based on the ability of 
the TCRs to react with host MHC molecules, which are mostly occupied with self-
peptides (Starr et al., 2003).  Continued interactions between TCRs and peptide-MHC 
molecules contribute to the maintenance and homeostatic expansion of mature T-cells in 
the periphery (Bender et al., 1999; Ernst et al., 1999), thus reshaping the peripheral T-cell 
repertoire.  These processes allow the immune system to maintain a T-cell repertoire 
containing sufficient diversity and specificity to respond against an unknown and highly 
diverse pathogen pool. 
 
In Chapter 4 we showed that Treg repertoire is highly diverse with distinct set of 
TCRs compared with Tconv cells, though with some overlap between populations both in 
unimmunized mice and in mice with EAE.  However, the role of TCR specificity in 
directing thymic precursors into the Treg or Tconv linage remains unclear.  Some studies 
indicated TCR specificity is crucial to Treg differentiation.  T-cells exclusively 
expressing the transgenic TCR appeared incapable of undergoing CD4+CD25+ Treg cells 
selection.  However, the introduction of cognate peptide into the repertoire of self-
peptides can induce the formation of CD4+CD25+ Treg cells expressing the clonotypic 
transgenic TCR.  For example, Treg cell development was seen when TS1 TCR 
transgenic mice were mated with mice containing cognate ligands (HA28).  The 
formation of Treg cells has also been described in mice expressing HA under the control 
of an immunoglobulin promoter in RAG-deficient backgrounds (Apostolou et al., 2002; 
Jordan et al., 2001).  Likewise, when DO11.10 TCR transgenic mice were crossed with 
RAG-/- mice expressing cognate peptide - ovalbumin (OVA), CD4+CD25+ Treg cells 
were also formed (Kawahata et al., 2002; Walker et al., 2003).  These findings suggested 
that the activation by agonist ligands in thymus could promote Treg cell formation.  This 
together with the utilization of different TCRs in Treg than Tconv cells implies that 
thymocytes possessing self-antigen specificity are more likely to develop into Treg cells.  
On the other hand, Treg cells can recognize a wide range of foreign antigens, have a 
diverse TCR repertoire, and no increased reactivity of Treg cells toward self was 
identified in one analysis of T-cell hybridomas derived from Treg and Tconv cells 
(Pacholczyk et al., 2007).  Therefore, we cannot completely exclude the possibility that 
TCRs with weak affinity to self or that are not self-reactive will be included in Treg 
repertoire.   
 
Though TCR repertoire analysis is powerful in picturing the overall relationship 
between Treg and Tconv cells, it is limited in that inferences are made by population 
shifts in the absence of specific knowledge about antigen specificity.  Likewise, studies 
of antigen reactivity among Treg and Tconv cells have typically been performed outside 
of the context of repertoire analyses that illuminate relationships between T-cell 
populations.  To better clarify the specificity and responsiveness of Treg cells, in this 
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chapter, we focused the studies on a cohort of TCRs identified in Chapter 4, reconstituted 
into the CD4+ TCRαβ-deficient 4G4.CD4 T hybridoma.  We were thereby able to 
determine the frequency of MOG-specific auto-reactive TCRs in Treg and Tconv cells 
populating the CNS and spleen.  The experiments answered the following questions: Are 
Treg or Tconv cells present in the CNS during MOG-EAE more prone to be MOG-
specific than those in the spleen, and the frequencies of MOG-specific cells differ 
between Treg and Tconv cells.  What are the sensitivity and fine specificity differences 
among the self-reactive Treg and Tconv TCRs?  Are there differences in the CDR3 
features of MOG-specific TCR from Treg and Tconv cells?  This analysis may give clues 
as to how the nature of the TCR itself impacts on the fate of Tcells: to become Treg or 
Tconv?  Localize to CNS or periphery?  
 
 
5.2 Results 
 
 
5.2.1 MOG-specificity among Treg and Tconv TCR 
 
To better delineate the properties of the responding TCR present within the CNS 
and periphery during EAE, we recreated full-length αβ TCR cDNAs from 40 identified 
CDR3 sequences (Table 5-1).  The CDR3 were selected from sequences identified at high 
frequency (all were among the 50 most commonly identified sequences) to provide an 
approximately equal distribution of predominantly Foxp3+ and Foxp3− CDR3 of splenic 
or CNS origin.  As above (Figures 4-3, 4-4 and 4-5), TCR with sequences shared by both 
Treg and Tconv cells were heavily skewed toward a single cell class (Table 5-1, far right 
column).  A high representation of public TCR was seen among the selected CDR3 
(21/40 sequences), reflecting the increased frequency of these sequences among common 
TCR.  Reconstituted TCR were subcloned into a tricistronic retroviral vector essentially 
as we have previously described (Alli et al., 2008), with TCR α and β chains linked by 
the Thosea asigna virus 2A sequence to facilitate their stoichiometric expression and an 
IRES-linked cyan fluorescent protein (CFP).  TCR-encoding retrovirus for these and the 
original 1MOG244.2αβ TCR were transduced into the CD4+ TCRαβ-deficient 4G4.CD4 
T-cell line (Figure 5-1).  The cells were flow cytometrically sorted for similar TCR 
expression levels and stimulated with MOG35-55 peptide, and IL-2 production was 
measured as an indicator of MOG responsiveness.   
 
MOG-specificity varied among the TCR cohorts (Figure 5-2).  2/12 (16.7%) of 
splenic Foxp3− TCR from immunized mice responded to MOG, whereas 1/8 (12.5%) of 
splenic Foxp3+ TCR responded.  In contrast to this more modest representation of MOG-
specific cells in the periphery, 8/8 (100%) of CNS Foxp3− and 6/12 (50%) of CNS 
Foxp3+ TCR-transduced cells produced IL-2 in response to MOG.  These results 
therefore demonstrate substantial enrichment of MOG-specificity within CNS-infiltrating 
Tconv cells of mice with EAE.  Further, despite the evidence from our repertoire analyses 
for limited interconversion between Tconv and Treg cells and the use of a TCRα in the 
retrogenics derived from a Foxp3− T-cell, a substantial proportion of the Treg cell 
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Table 5-1. Features of CDR3β used to reconstitute full-length TCR cDNA. 
 
Clone 
# Site 
MOG-
specific Foxp3+ Sequence Length Public
Foxp3+ 
TCR 
Foxp3- 
TCR 
Foxp3+/Foxp3- 
ratio 
4 Spl N N ASGDGGLGGRGEQY 14 Y 0 18  
7 Spl N N ASGEKAEYEQY 11 Y 1 15 0.067 
10 Spl N N ASGTGGYSYEQY 12 N 2 82 0.024 
17 Spl N N ASGRQSSYEQY 11 N 0 15  
30 Spl N N ASGGGSYEQY 10 N 0 17  
31 Spl N N ASGAPDWGVPEQY 13 N 3 33 0.090 
32 Spl N N ASGEKTEYEQY 11 N 2 30 0.067 
36 Spl N N ASGDDWGGAYEQY 13 Y 6 14 0.43 
37 Spl N N ASGDGLASSYEQY 13 Y 2 20 0.1 
47 Spl N N ASGPVEQY 8 Y 1 13 0.077 
5 CNS N Y ASGDWDNYEQY 11 Y 35 10 3.5 
8 CNS N Y ASGGYEQY 8 Y 33 2 16.5 
15 CNS N Y ASGRDRGLEQY 11 N 18 0  
20 CNS N Y ASGDWDVYEQY 11 N 14 0  
34 CNS N Y ASGDGTGGVEQY 12 Y 26 1 26 
39 CNS N Y ASGDARLGGREQY 13 Y 20 0  
3 Spl N Y ASGDGEQY 8 Y 86 8 10.8 
14 Spl N Y ASGGEVYEQY 10 N 16 0  
24 Spl N Y ASAGWGLYEQY 11 N 7 0  
26 Spl N Y ASGEGGFSYEQY 12 N 20 0  
28 Spl N Y ASGDDWAYEQY 11 N 13 0  
41 Spl N Y ASGRGTGGYEQY 12 Y 19 0  
46 Spl N Y ASGDAWGVYEQY 12 Y 15 0  
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Table 5-1. Continued. 
 
Clone 
# Site 
MOG-
specific Foxp3+ Sequence Length Public
Foxp3+ 
TCR 
Foxp3- 
TCR 
Foxp3+/Foxp3- 
ratio 
6 CNS Y N ASGEPGQSSYEQY 13 Y 2 12 0.17 
11 CNS Y N ASGDAGISYEQY 12 Y 7 32 0.22 
12 CNS Y N ASGDAGSSYEQY 12 Y 1 8 0.13 
19 CNS Y N ASGDSGGVYEQY 12 Y 3 15 0.2 
21 CNS Y N ASGDAGQAYEQY 12 Y 1 45 0.022 
29 CNS Y N ASGEAGGAYEQY 12 Y 3 14 0.21 
45 CNS Y N ASGDPGSSYEQY 12 N 0 16  
44 Spl Y N ASGDASRGYEQY 12 N 0 16  
50 Spl Y N ASGEGGGHYEQY 12 Y 0 12  
244.2* Spl Y N ASGDAGTGYEQY 12 Y 0 7  
1 CNS Y Y ASGASGGLYEQY 12 N 13 1 13 
9 CNS Y Y ASGLTDEQY 9 N 25 0  
16 CNS Y Y ASGATGAPYEQY 12 N 16 0  
18 CNS Y Y ASGVPGQGVEQY 12 N 13 0  
52 CNS Y Y ASGAPGGSYEQY 12 Y 11 0  
110 CNS Y Y ASGVPGQGGEQY 12 N 11 0  
35 Spl Y Y ASGAPGHPYEQY 12 Y 22 0  
 
 
Note: Clone #, site of primary isolation, MOG-specificity, association with Foxp3 expression, CDR3 length, isolation from multiple 
experiments (public) and frequency of identification from Foxp3+ and Foxp3- cDNA is indicated. *, original 1MOG244.2TCR. 
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Figure 5-1. Expression of TCR on CD4.4G4 cells.  TCR was retrovirally transduced 
into CD4.4G4 cells and cytometrically sorted for CD4+TCR+ population.  Sorted cells 
were expanded for 3-4 days, and TCR expression was analyzed using anti-TCR 
antibody.   
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Figure 5-2. MOG-specificity among isolated TCR.  Forty CDR3β, distributed among 
Foxp3+ and Foxp3− isolates from the CNS or spleen, were used to construct retrovirus 
incorporating full-length αβ TCR.  Retrovirally transduced 4G4.CD4 T-cells were flow 
cytometrically sorted for similar surface expression of TCR and stimulated with Tcra−/− 
splenic APC with or without 100μg/ml MOG35-55 peptide or with plate-bound CD3 
antibody.  IL-2 production was measured in cell-free supernatant at 24 hr by ELISA.  
Data indicate mean + 1 SEM and are representative of three or more assays for each 
TCR. 
 
 
 
 
59 
 
 
response was directed against MOG.  This indicates that regulatory T-cells in MOG-EAE 
respond to cognate autoantigen. 
 
 
5.2.2 Segregation of MOG-Specific Treg and Tconv Cell TCR Based on CDR3β 
Characteristic 
 
Sequence information for all MOG-specific and nonspecific TCR was compared 
(Table 5-1).  This provided several insights.  First, MOG-specific CDR3β, Foxp3+ or 
Foxp3−, bore a consistent length of 12 (11.9 ± 0.8; 15/18 [83%] sequences length of 12).  
The non-MOG-specific TCR showed only slightly decreased average length (11.2 ± 1.6), 
but many fewer 12 amino acid sequences (5/23; 23%) and more diversity in this measure.  
MOG-specific TCR further more consistently had a G at the 6th CDR3 position (16/18; 
89%) compared with non-MOG-specific TCR (4/23; 17%), implying that the absence of 
a side chain in that position is important for antigen recognition.  More interestingly, 
among the MOG-specific TCR, CDR3 sequence distinguished TCR derived from 
primarily Foxp3+ and Foxp3− T-cells.  Acidic D or E residues were present at position 4 
in 11/11 (100%) of Foxp3− but 0/7 (0%) of Foxp3+ MOG-specific CDR3.  D and E would 
be anticipated to have a high prevalence at this location; a D is formed with Vβ8.2-Dβ 
recombination in the absence of junctional mutations or with a C→T replacement at the 
first D-region nucleotide.  An E is formed with a C→A or G replacement at the same 
nucleotide.  Indeed, 5/10 (50%) of Foxp3− and 8/13 (62%) of Foxp3+ nonspecific CDR3 
bore a D or E at position 4, making its complete absence more surprising in the Foxp3+ 
MOG-specific population.  In contrast, 100% of the MOG-specific Foxp3+ TCR bore an 
aliphatic A (4/7), V (2/7), or L (1/7) residue at that location, residues seen in only 1 of the 
34 other CDR3 examined.  Therefore, TCR expressed by MOG-specific Treg and Tconv 
cells comprise distinct families.  Implicitly, these cells undergo a distinct selection 
process in 1MOG244.2α mice that is either not based on MOG recognition or is based on 
differential recognition of MOG. 
 
 
5.2.3 Sensitivity and Fine Specificity of MOG-specific TCR for Auto-antigen 
 
Current models of Treg cell lineage specification suggest that Treg cells possess a 
proclivity for self-reactivity and that thymocytes with higher affinity for self-antigen are 
diverted into the Foxp3+ lineage (Pacholczyk and Kern, 2008).  MOG is expressed in the 
thymus, though in small amounts (Delarasse et al., 2003).  If MOG is responsible for the 
selection of MOG-reactive Treg cells, then these cells would be anticipated to bear an 
increased affinity for it.  Because the 4G4.CD4 TCR transductants were essentially 
identical except for the sequence of their TCR CDR3β, their relative sensitivity to Ag 
should primarily reflect their affinity.  We therefore tested the sensitivity of all MOG-
specific TCR to dilutions of MOG35-55 peptide (Figure 5-3).  Interestingly, although Treg 
cell TCR trended toward increased sensitivity, substantial overlap was observed between 
the MOG-specific Treg and Tconv cell TCR.  In each case, receptors were identified with 
high, moderate, and low sensitivity for MOG.  Moreover, specific pairs of Foxp3+ and 
Foxp3− CDR3 with conserved amino acid sequences showed similar sensitivities for  
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Figure 5-3. Sensitivity of MOG35-55-specific TCR for autoantigen.  MOG-specific 
4G4.CD4 transductants were assayed for relative sensitivity to antigen.  Cells bearing 
Foxp3- (A) or Foxp3+ (B) T-cell derived TCR were analyzed as in Figure 5-1 but 
stimulated with varied doses of MOG35-55 peptide.  All cell lines were simultaneously 
analyzed for comparability.  Data shown is representative of 3 independent experiments 
with at least 2 independent transductions of each TCR. 
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antigen (Table 5-1 and Figure 5-3).  Clones 19 (Foxp3−) and 1 (Foxp3+), which besides 
the variation at position 4 only have a conserved V→L substitution at position 8, both 
responded vigorously to MOG stimulation.  Clones 45 (Foxp3−) and 52 (Foxp3+), which 
differ only at position 4 and by a S→ G at position 7, also responded similarly and more 
moderately.  Therefore, although Treg cells tend toward increased sensitivity for MOG, 
this does not seem to be encoded into the position 4 variation and a MOG sensitivity 
threshold does not appear fundamental to response by Treg versus Tconv cell TCR. 
 
These results suggest that other factors affected by the position 4 variation, for 
instance differential fine specificity for MOG or sensitivity to an alternative cross-
reactive selecting Ag(s), are responsible for Treg cell lineage assignment.  To test the 
former possibility, we examined the fine specificity of recognition of five of the MOG-
specific Foxp3− TCR, including the index 1MOG244.2TCR, and four of the Foxp3+ TCR.  
Prior studies with MOG35-55-specific TCR have identified critical TCR interacting 
residues, particularly R41, F44, R46, and V47 (Petersen et al., 2004).  The different TCR 
demonstrated variability, through common patterns of reactivity when tested with 
alanine-substituted MOG35-55 peptides (Figure 5-4).  An R41A substitution did not 
substantially influence recognition for 1MOG244.2 or most of the other TCR, whereas 
response was diminished to F44A, R46A, and V47A substitutions.  However, with these 
and alanine substitutions at all residues from V37 to L50, no pattern was identified that 
distinguished the fine specificity of the Foxp3+ and Foxp3− T-cell-derived TCR.  
Therefore, differential recognition of cognate MOG antigen does not appear to be 
associated with the binary differentiation of T-cells with acidic or aliphatic residues at 
CDR3β position 4 alternatively into Tconv or Treg cells.  Considering the absence of 
evidence for affinity or fine specificity-based segregation of Tconv and Treg cell TCR, 
our data would suggest that a MOG sensitivity threshold is not itself responsible for 
MOG-specific Treg cell recruitment, and presumably also lineage assignment. 
 
 
5.2.4 Fidelity in TCR Lineage Specification 
 
The 1MOG244.2α retrogenic mice were produced with Tcra−/− HPC donor and 
recipient mice.  We were interested whether the MOG-specific Treg and Tconv cell TCR 
that we identified in 1MOG244.2α mice (Table 5-1) would similarly guide differentiation 
in a distinct system where the thymus is from a wild-type and not Tcra−/− mouse and most 
developing T-cells are unmanipulated.  To test this, we transduced MOG-specific TCRαβ 
pairs into CD45.1−CD45.2+ Rag1−/−HPC, which cannot express other TCR.  These were 
diluted with an excess of congenic CD45.1+CD45.2− T-cell-depleted bone marrow cells 
and transplanted into CD45.1+CD45.2− mice.  Seventeen mice demonstrated detectable 
CD45.2+CD4+ T-cell engraftment (range 0.001%–8.5% of CD4+TCR+cells), including 
mice expressing three TCR derived from Treg cells (#1, 9, 18, Table 5-1) and four from 
Tconv cells (#2, 6, 21, 45) (Figure 5-5).  Overall, the Treg cell-derived TCR showed >20-
fold increased engraftment into the Foxp3+ lineage when compared with the Tconv cell 
TCR (mean of Foxp3+ cells: 21.4% ± 10.6%; of Foxp3− cells: 0.95% ± 1.1%).  Therefore, 
cells expressing TCR derived from Tconv cell TCR in 1MOG244.2α mice differentiate 
into Tconv and not Treg cells in this system.  Cells expressing TCR derived from Treg  
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Figure 5-4. Fine specificity of Foxp3+ and Foxp3- TCR.  The indicated 4G4.CD4 cell 
lines expressing Foxp3+ or Foxp3--derived TCRs were stimulated with irradiated Tcr-/- 
APCs in the absence of antigen or in the presence of 100µg/ml MOG35-55 or the indicated 
alanine-substituted mutants of this peptide.  IL-2 was measured in cell free supernatant at 
24 h as an indicator of stimulation.  Percent IL-2 production compared with MOG35-55 
stimulation is plotted.  Bars indicate from left to right IL-2 production by clones 
6,21,29,45,244.2,1,16,18 and 35 after stimulation with the indicated peptide.  Mean + 
SEM is plotted. 
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Figure 5-5. Foxp3 expression among CD4+ T-cells in TCR‐retrogenic mixed 
chimeras.  To evaluate the lineage preference of MOG‐specific Treg or Tconv TCR 
identified from1MOG244.2α mice in mice with a wild-type thymus and few transgenic 
precursor cells, we produced mixed chimeras using select cloned TCR.  Retroviral 
constructs incorporating the TCRαβ from MOG‐specific Treg‐derived TCR clones 1, 9, 
and 18, and Tconv derived clones2, 6, 21, and 45 were transduced into B6.129S7-
Rag1tm1Mom /J HPC.  The Rag1 deficiency ensures that all T-cells developing from the 
transduced population express the TCR transgene.  An ~1‐5% transduction efficiency 
was obtained. The HPC were mixed at a 1:1 or 1:10 ratio with untransduced, wild-type, 
T‐cell depleted CD45.1 congenic B6.SJL-PtprcaPep3b.BoyJ‐derived bone marrow, and 
transplanted into B6.SJL-PtprcaPep3b.BoyJ mice.  At 6‐8 weeks after transplant, mice 
were sacrificed, and splenocytes stained with CD45.2, TCR, CD4, and intracytoplasmic 
Foxp3 antibodies.  (A) Flow cytometric analysis shows Foxp3 expression on 
CD45.2‐CD4+TCR+ or CD45.2+CD4+TCR+ gated populations.  (B) Engraftment and 
percent Foxp3 positivity among TCR‐transduced CD45.2+ T-cells is indicated. Percent 
engraftment of CD4+CD45.2+ T-cells was calculated as 100 x (number of 
CD45.2+CD4+TCR+ cells identified) / (total number of CD4+TCR+ cells). Percent Foxp3+ 
T-cells is calculated as 100 x (number of CD45.2+CD4+TCR+Foxp3+ cells) / (total 
number of CD45.2+CD4+TCR+ cells).   
 
64 
 
 
cell TCR in 1MOG244.2α mice show increased Treg cell bias.  Although not all of the 
retrogenic T-cells expressing the Treg cell-derived TCR developed into Foxp3+ cells, this 
is not surprising because niche saturation for Treg cell development may occur even at 
very small numbers of Ag-specific T-cells (Bautista et al., 2009).  Despite heavy dilution 
with wild-type cells in these mixed chimeric mice, cells expressing the assayed TCR 
should nevertheless be increased in frequency compared with 1MOG244.2α mice.  
Therefore, Treg and Tconv cell lineage assignment in the 1MOG244.2TCRα retrogenic 
mice is paralleled in a distinct and arguably more natural system, one in which the thymic 
stroma and the large majority of T-cells are wild-type. 
 
 
5.3 Summary 
 
In this chapter, we selected 40 high frequency TCRs identified in Chapter 4, 
transduced them into CD4.4G4 hybridomas, and analyzed their responsiveness to 
MOG35-55.  We found that autoreative Tconv cells were highly enriched in the CNS 
(100% of TCR), but not spleen, of 1MOG244.2TCR mice with EAE.  50% of CNS-
infiltrating Treg cells were also MOG-reactive.  This result confirms the presence of 
auto-antigen reactive T-cells accumulating in CNS of mice with EAE, and indicates that a 
large percentage of Treg TCR are MOG-reactive.   
 
MOG-specific and non-specific TCRs showed distinct CDR3 sequence features.  
MOG-specific TCRs uniformly bear a length of 12 amino acids, and a glycine at position 
6.  More importantly, among MOG-specific TCRs, Treg and Tconv TCR possess distinct 
characteristics.  Aspartic acid or glutamic acid at position 4 were exclusively seen in 
Tconv TCR, whereas aliphatic residues – alanine, valine and leucine were found in Treg 
TCR.  This suggests that Treg and Tconv cells during EAE arise from distinct population 
repertoire.   
 
Analysis of sensitivity differences between MOG-specific Treg and Tconv cells 
showed similar and overlapping responsiveness.  Further differential fine specificity for 
MOG35-55 was not identified in Treg and Tconv TCRs.  This implies two possibilities; 
one is that MOG35-55 is not responsible for T-cells lineage assignment and alternative 
Ag(s) should be considered, the other is that affinity threshold is not fundamental for 
Treg cell selection.   
 
To ensure the lineage commitment of Treg and Tconv cells seen in 
1MOG244.2TCR mice can also be observed in a more normal thymic environment, we 
transplanted highly diluted Rag-/- HPCs expressing MOG-specific Treg or Tconv TCRs 
into congenic wild-type mice.  The same lineage specification was readily observed as in 
retrogenic mice, suggesting that TCR-driven Treg and Tconv cell differentiation 
identified in 1MOG244.2TCR mice is indicative of the differentiation potentials of the 
same TCR in normal thymus as well.   
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CHAPTER 6.  DISCUSSION 
 
 
6.1 Introduction 
 
In Chapters 3-5, we demonstrated through studies of repertoire and individual 
TCR only limited overlap between Treg and Tconv cells responding during MOG-EAE.  
MOG-specific Treg cells formed a substantial though not exclusive component of the 
CNS-infiltrating Treg cell repertoire.  Examination of MOG-specific Treg and Teff cell 
TCR with a fixed TCRα and restricted TCRβ usage failed to find evidence for sensitivity 
or fine specificity for MOG influencing Treg versus Tconv cell lineage assignment, but 
did reveal lineage segregation based on conserved CDR3 features.  Our results favor a 
model in which Treg cell response during EAE is developmentally encoded in the TCR 
repertoire and argue against anything more than limited plasticity between Treg and 
Tconv cells during the autoinflammatory response. 
 
In this chapter we will discuss the following problems and future plans: Are 
1MOG244.2TCR mice an optimal model to study T-cell repertoire?  Does 
interconversion play an important role in maintaining Treg population in the 
inflammatory environment?  What is the source of CNS-infiltrating Treg cells in MOG-
EAE?  Do self-reactive Treg cells show higher sensitivity to self-antigen than Teff cells 
do?  Is MOG the only antigen CNS-infiltrating T-cells recognize in MOG-EAE?  Does 
epitope spread and cross-reactivity influence the regulatory response in MOG-EAE?   
 
 
6.2 Developing a Retrogenic Model of EAE to Facilitate Repertoire Analysis 
 
 
6.2.1 Why Does the TCR Chain Need to be Fixed? 
 
The purpose of fixing one TCR chain is to limit TCR variability and help 
determine the specificity of TCR repertoire.  With one TCR chain fixed, it is only 
necessary to define the second chain’s sequence, eliminating the need to clone both 
chains from a single cell.  Previous data showed that TRBV13-2 (V8.2) was highly 
associated with auto-reactivity in EAE, with nearly half of auto-reactive MOG-specific 
T-cells expressing V (Mendel et al., 1995; Mendel Kerlero de Rosbo and Ben-Nun, 
1996; Offner et al., 1992), whereas TRAV use (V) is much more variable.  By fixing 
the TCR chain and studying TCR, we are able to focus on the disease relevant V8.2+ 
TCR population.  In addition, the CDR3 region shows greater diversity (V-N-D-N-J) 
than the CDR3 (V-N-J), suggesting that the TCR chain will have increased variability 
compared with the TCR.  A bias towards particular V gene families was also seen in 
virus infection, autoimmunity and alloreactivity models (Aebischer et al., 1990; Baker et 
al., 2002; Callan et al., 1996; Kedzierska et al., 2004; Oksenberg et al., 1993; Pantaleo et 
al., 1994; Torres-Nagel et al., 1997; Trautmann et al., 2005).  This might be a 
consequence of the limited number of available mouse TCR V gene segments (35) 
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compared with a greater number of mouse V gene segments (71) (Lefranc et al., 1999).  
Thus studying TCR chain repertoire will potentially yield valuable information, 
particularly on the MOG-specific response.   
 
 
6.2.2 Does a Fixed  Chain Influence the Course of MOG-EAE Significantly? 
 
One concern in retrogenically fixing TCR, is that the timing of TCR chain 
expression in the thymus is not physiological and may affect the repertoire.  In thymic 
development, TCR chain rearranges first in DN cells, followed by the formation of 
TCR/pT/CD3/TCRζ2 complexes.  The pre-TCR triggers the signal transduction 
cascade by activating the kinase Lck, engaging the adaptor SLP-76 and linker of 
activated T-cells (LAT), and thus activating protein kinase C, Ras, and MAP kinases 
(Gartner et al., 1999; Hagenbeek et al., 2004; Iritani et al., 1999; Schmedt and 
Tarakhovsky, 2001).  Comparison of T-cell development in mice with a TCR transgene 
and lacking pT, and mice lacking a transgene but with wild-type pT suggests that 
TCR complexes are less effective than pT complexes in supporting proliferation, 
survival, and  T-cell lineage commitment of early T-cell progenitors.  This is due to 
intrinsic differences in signaling capability of the different complexes (Baldwin et al., 
2005; Borowski et al., 2004; Huang and Kanagawa, 2004; Lacorazza et al., 2001).  To 
avoid this circumstance, many repertoire analyses have been performed on TCR 
transgenic mice, studying the TCR repertoire (Hsieh et al., 2004; Pacholczyk et al., 
2006; Wong et al., 2007b) 
 
For the reasons listed above, we nevertheless selected to fix the TCR rather than 
TCR chain.  To evaluate the impact of the retroviral transgene on T-cell development, 
we conducted flow cytometeric analyses of thymocytes from 1MOG244.2 retrogenic and 
wild-type C57BL/6 mice.  No significant difference of DN, DP, SP subpopulations 
between retrogenic and WT mice were seen between retrogenic and WT mice.  More 
significantly the DN3 to DN4 transition, when pT signaling appears most important did 
not appear affected by the 1MOG244.2 transgene (Figure 3-2).  This suggests that the 
early TCR expression does not inhibit thymocytes from passing through the DN3 to 
DN4 checkpoint, or diminish the efficiency of positive selection in 1MOG244.2 
retrogenic mice.   
 
We did observe repertoire alterations in the periphery of retrogenic compared with 
wild-type mice.  First, different use of V segments in 1MOG244.2TCR retrogenic 
mice was observed.  For example, V14 was substantially increased in retrogenic mice (p 
< 0.05), and V3, V4, V8.3 were decreased (Figure 3-4).  Second, the peripheral T-
cell repertoire in 1MOG244.2TCR is skewed to the CD4 compartment.  The ratio of 
CD4/CD8 T-cells reaches 5-10 in LN and spleen, implying that the transduced  chain 
favors CD4+ T-cell selection or expansion in the periphery.  A similar skewing to the 
CD4 lineage has been seen in C6 TCR Tg female mice (Furmanski et al.).  Third, 
retrogenic mice with different  transgenes have distinct susceptibilities to EAE (Figure 
3-1A).  Four different retrogenic mice expressing distinct  chains were challenged with 
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MOG, and only 1MOG244.2TCR showed EAE that caused peak disease levels 
comparable to WT mice, though they have delayed onset of disease.  These results 
suggest that the  transgene has potential impact on T-cell selection and may alter the 
repertoire to some extent.   
 
Does this change influence our experimental results?  It is to be expected that the 
manipulation inherent in fixing TCR will limit the repertoire of TCR, as many 
rearranged TCR will not pair with this TCR.  V distribution in splenic Tconv cells is 
as diverse as WT mice, and V8.1/8.2 is predominately used.  After immunization with 
MOG35-55 peptide, 1MOG244.2 develops EAE with similar disease severity as WT, and 
CNS-infiltrating T-cells predominately use V8.1/8.2 as described in C57BL/6 mice 
(Mendel et al., 1995; Mendel Kerlero de Rosbo and Ben-Nun, 1996).  Most importantly, 
the percent of Treg among CD4+ T-cells in thymus, LNs, and spleen is 3.20% ± 1.06%, 
12.84% ± 2.24%, and 7.50% ± 2.41% respectively, which is similar to those in wild-type 
mice.  This argues against impaired development of Treg cells.  Taken together, the 
repertoire is altered in 1MOG244.2 mice, but remains diverse.  Further, that diversity is 
present in both the Treg and Tconv populations.  Nevertheless, it is important to 
experimentally document that the Treg versus Tconv lineage specification we observed in 
1MOG244.2TCR mice would be similarly seen in a more normal situation (Section 
5.2.4), and these studies are ongoing.   
 
 
6.2.3 Fixing the TCR 
 
T-cell receptor (TCR) transgenic mice are widely used and have had a large 
contribution to understanding of T-cell development and signal transduction.  Previous 
repertoire analyses relied on transgenic mice which had fixed  chain with or without a 
TCR chain minilocus (Hsieh et al., 2004; Malherbe et al., 2004; Wong et al., 2007b).  
However, TCR transgenic mouse production is time consuming and costly. 
 
To avoid this, we utilized retrogenic mice in which specific TCRs are retrovirally 
transduced into hematopoietic stem cells (Holst et al., 2006b).  This approach is 
substantially faster than making trangegnic mice, (6 weeks versus 6 months), and 
engraftment is reproducible from mouse to mouse.  Also, mice containing different fixed 
 chains can be examined simultaneously.  Since these mice are individually generated 
and each of them is a founder, the potential bias introduced by a founder effect would be 
limited (Holst et al., 2006b).  However, there are still several disadvantages to retrogenic 
mice.  For instance, the number of T-lymphocytes obtained from retrogenic mice is 
generally 3-4 fold less than that from Tg mice.  Pooling mice was necessary to obtain 
enough CNS-infiltrating Treg cells for RNA extraction and TCR repertoire analysis.  
Retrogenic mice have to be constantly generated.  Also, because T-cells first develop in 
transplanted adult mice (6-8 weeks) rather than the neonatal environment, an increased 
memory-like phenotype of peripheral T-cells may result as T-cells form in a lymphopenic 
environment.  Finally, we sub-lethally irradiated recipient mice to facilitate stem cell 
engraftment, and irradiation itself can generate inflammation and enhanced cytokine 
secretion that may last up to 6 weeks (Holst et al., 2006b).  Although we have not seen 
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any deleterious consequences per se, these effects can potentially influence experimental 
results and should be considered in interpreting data from the system.  
 
 
6.3 Interconversion and Origins of Treg and Tconv Cells in Autoimmunity 
 
The Treg cells largely originate in the thymus.  Seemingly, encounter with self-
antigens at intermediate affinity induces Treg cell differentiation (Apostolou et al., 2002; 
Hsieh et al., 2004; Jordan et al., 2001; van Santen et al., 2004).  This results in the 
generation of a largely distinct TCR repertoire in Treg and Tconv cells, as indicated by 
studies of TCR CDR3 sequences in transgenic systems.  On the other hand, a noticeable 
overlap, ranging from 10 to 42% between Treg and Tconv is also observed (Hsieh et al., 
2004; Hsieh et al., 2006; Pacholczyk et al., 2006; Pacholczyk and Kern, 2008; Wong et 
al., 2007b).  One hypothesis is that interconversion may play a role in generating the 
overlap between Treg and Tconv cells, and this interconversion involves either 
upregualtion of Foxp3 in Tconv or loss of Foxp3 in Treg cells (Hoffmann et al., 2009).   
 
The conversion of Tconv into Treg can be achieved both by TGF and IL-2 or 
retinoic acid (RA) exposure during activation in vitro (Chen et al., 2003; Wang et al., 
2009), or chronic exposure to antigen delivered by osmotic pumps or by antibody 
mediated targeting in vivo (Apostolou and von Boehmer, 2004; Cobbold et al., 2004; 
Knoechel et al., 2005; Kretschmer et al., 2005).  Mechanistic studies have provided a 
framework to explain the plasticity between Treg and Tconv cells, with selective 
signaling pathways regulating Foxp3 expression (Coombes et al., 2007; Mucida et al., 
2007; Quintana et al., 2008; Selvaraj and Geiger, 2007).  In addition, conversion was 
readily seen in the studies involving adoptive transfer of purified CD4+CD25- or 
CD4+Foxp3- T-cells into lymphopenic or lymphoreplete hosts, with conversion varying 
from 0.3% to 12% (Curotto de Lafaille et al., 2004; Fontenot et al., 2005b; Lathrop et al., 
2008; Liang et al., 2005).  If one extrapolates the behavior of the adoptively transferred 
population as representative of their respective T-cell population, 0.4% and 8% 
conversion in periphery of normal mice would contribute to 3.6% and 72% of the Treg 
cells, respectively (Lathrop et al., 2008).  This is a very large range and the higher 
numbers are not consistent with other repertoire studies.  Thus conversion in the 
periphery was seen in several studies, though to what extent it maintains the peripheral T-
cell population is still controversial. 
 
Whether interconversion influences active immune responses, and more specific 
cells participating in autoimmunity, is uncertain.  Some results suggest that adaptive 
upregulation of Foxp3 plays an important role in modulating autoimmunity 
(Manicassamy et al., 2009; You et al., 2007).  Other studies failed to identify a role for 
Foxp3 induction (Korn et al., 2007; Wong et al., 2007a).  During EAE, T-cells activated 
in the periphery migrate to the CNS where they re-engage antigen on local dendritic cells 
and expand (Bailey et al., 2007).  The early CNS response has a low frequency of Foxp3+ 
T-cells, suggesting that substantial numbers of Treg cells are not stimulated to enter the 
CNS at this time.  Yet Treg cells accumulate later in the disease and are associated with 
resolution (McGeachy et al., 2005).  Therefore, either migration or expansion of this 
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population is delayed or CNS-infiltrating Treg cells are forming through Tconv cell 
conversion.   
 
There are several possible explanations for how interconversion can influence 
Tconv and Treg cells in MOG-EAE.  First interconversion may be a rare event in 
lymphoid organs with little target antigen.  But once challenged by MOG, the T-cells will 
migrate to the CNS where the activated T-cells will encounter antigen in varied settings, 
and interconversion may occur.  With this possibility we would expect to observe little 
overlap of Tconv and Treg in preimmune and little to moderate overlap in postimmune 
spleen, and much greater overlap in CNS (Figure 6-1A).  A second possibility is that 
interconversion occurs frequently in periphery of normal individuals, and inflammation 
may or may not change the interconversion rate.  In this case we would observe 
substantial overlap between Tconv and Treg cells in preimmune spleen, postimmune 
spleen and CNS (Figure 6-1B).  A third possibility is that interconversion occurs 
infrequently in unimmunized organs, and antigen exposure or inflammatory environment 
does not facilitate interconversion.  In this case, we would observe a limited overlap 
between Treg and Tconv in preimmune spleen, postimmune spleen and CNS (Figure     
6-1C).  Finally, it is possible that interconversion occurs most prominently with the initial 
immunization.  In this case, we would expect that MOG-specific T-cells would show a 
large degree of overlap in the postimmune periphery and CNS, but non-specific cells that 
are not activated with immunization would show lower degree of overlap (Figure 6-1D).   
 
At a population level, our data fail to identify a substantial role for interconversion 
as a means of locally generating Treg cells in the CNS.  First, limited overlap of TCR 
used by Tconv and Treg cells in CNS and spleen was observed.  And comparison of 
shared CDR3 amino acid sequences for each cohort demonstrated that the resemblance of 
repertoire among a single cell class (Treg or Tconv) across different organs (spleen and 
CNS) was greater than among different classes of cells within an organ.  This result 
suggests that a distinct TCR repertoire is used by Tconv and Treg cells.  Second, the 
frequencies of shared CDR3 among unique TCR sequences in preimmune splenocytes 
(expt 1: 3.5%; expt 2: 6.4%) was only modestly lower than that in postimmune 
splenocytes (expt 3: 10.1%, expt 4: 6.6%).  The difference between postimmune 
splenocytes and CNS-infiltrating cells (expt 3: 11%, expt 4: 14.7%) was likewise small.  
These trends may be consistent with limited interconversion between Treg and Tconv cell 
lineages, but indicates that EAE does not promote substantial interconversion.  It is 
correlated with the finding from NOD mice in which the encounter of cognate antigen in 
pancreas does not induce Tconv to Treg cell conversion (Wong et al., 2007a).  Third, the 
heavy skewing of the minority of expressed by both Treg and Tconv TCR toward a single 
cell type argues against extensive plasticity in Foxp3 expression during EAE.  Fourth, the 
acidic/aliphatic variation we observed in position 4 of MOG-specific TCR robustly 
discriminates between MOG-specific Treg TCR and Tconv TCR; implying auto-antigen 
specific Treg and Tconv populations are ontogenically distinct.  Therefore, our results 
showed limited interconversion between Treg and Tconv cells both in spleen and CNS 
during MOG-EAE, and support the third model that inflammatory environment does not 
promote substantial interconversion between Treg and Tconv populations either in the 
periphery or the CNS (Figure 6-1C).   
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Figure 6-1. Models of interconversion between Tconv and Treg cells in MOG-EAE. 
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6.3.1 Limitations of the TCR Repertoire Analysis 
 
Although our data argue against interconversion, we must point out the limitations 
of experimental strategy.  First, the sequence analysis was performed in two independent 
experiments.  Although similar results were found, it is worthwhile to repeat it multiple 
times to further confirm the result.  Second, the Tconv and Treg populations were 
separated by flow cytometry, and the sorting process can introduce a low level of error.  
Even though the purity of cell population was as high as 98%, 2% of cells could come 
from contamination and because of the larger number of Tconv cells, Tconv cells are 
more likely misplaced into Treg population, which may potentially exaggerate the 
overlap.  Third, we acquired all the TCR sequence information from isolated cDNA 
instead of from single T-cell clones.  This may introduce bias if differenT-cells express 
different amounts of TCR.  However, in regards to this it is important to note that our 
conclusions were identical based on analyses of unique TCR rather than total TCR 
isolates.  We also had to pool 5-6 mice together to harvest enough brain Treg cells for 
PCR.  Therefore representation of TCR from different mice may differ and this could 
skew the repertoire assessments if they had different quantities of infiltrating T-cells.  
This limitation may lead to decreased similarity between the two populations, and an 
underestimation of the degree of overlap.  However, we observed a dramatically 
increased overlap of single cell types across organs compared with differenT-cell types 
within one organ (~30% versus ~10%), and the result was reproducible, suggesting that 
skewing from pooling of organs did not alter our conclusions. 
 
Another difficulty in whole repertoire analyses is that all TCR are analyzed, 
including cells that are not specific to MOG35-55.  Tetrameric pMHC-MOG complex 
staining may be a better technique to directly sort out TCRs with high-affinity to   
MOG35-55.  However, autoreactive T-cells, including MOG-specific T-cells have low 
affinity, and the MOG-Ab tetramer only stains a minority of these cells.  We attempted to 
stain 1MOG244.2 and other T-cells with this tetramer, but signal was not adequate for 
analyses (R. Alli and T.L.G., unpublished observations).  We got around this problem by 
analyzing specific TCR for MOG reactivity.  When we characterized the properties of 
selected TCRs in vitro, 100% of Tconv and 50% of Treg TCR from cells infiltrating the 
CNS were MOG-specific, much higher than the published data of about 10% of MOG-
specific CNS-infiltrating T-cells using a MOG-Ab tetramer (Korn et al., 2007).  This may 
be due to that study’s inability to detect low affinity but pathogenic TCRs, or our 
repertoire analyses only including high frequent TCR.  It is possible that frequent T-cells 
may have a higher tendency toward MOG-specificity than low frequent T-cells.  
Nevertheless, despite its limitations, the approach we have used has a strong track record 
(Lin and Welsh, 1998; Pannetier et al., 1995; Sourdive et al., 1998), and has yielded new 
insights into the study of other repertoires.   
 
 
6.3.2 Future Studies 
 
To solve the problem generated by pooling cDNA, single-cell RT-PCR can be 
considered to acquire sequences of individual Tconv and Treg cells.  This will also 
72 
 
 
circumvent the problem of pooling mice to get enough T-cells from CNS, though it is 
technically more challenging and smaller numbers of sequences may be obtained.  
Alternatively, next-generation DNA sequencing can be used to confirm the limited 
conversion of Tconv and Treg cells (Freeman et al., 2009; Shendure and Ji, 2008).  With 
the help of massive parallel DNA sequencing, one can interrogate the repertoire more 
thoroughly and rapidly.  The whole analysis of 1MOG244.2 EAE could be repeated at 
higher resolution with different primer sets, such as V14-C and V-Cto confirm our 
results.  These experiments could also be performed at the different time point of disease 
– early onset or recovery phase, to see if there are temporal changes in interconversion 
between Foxp3+ and Foxp3- cells.  However, this scenario would seem unlikely 
considering our results indicating that interconversion between Foxp3- and Foxp3+ cells 
is minimal.  Additionally, the 1MOG244.2TCR thymocytes repertoire has not been 
studied yet, comparing Treg and Tconv TCR in thymus, spleen and CNS will give more 
information and allow us to trace TCR clonotypes to the thymus.   
 
Furthermore, experiments on the V8.2 repertoire of C57BL/6 mice with EAE 
can investigate the trend of interconversion in spleen and CNS in wild-type mice.  It 
would be interesting to know whether the D/E to A/V/L variation we found in retrogenic 
mice is also seen in wild-type mice with multiple  chains.  Finally, repertoire analyses 
on peripheral T-cells from MS patients have not been performed, and such analyses may 
test whether results in EAE model is correlated with MS.  One caveat here is that the cell 
surface markers for isolation of human Treg are imperfect, and isolation of pre Treg and 
Tconv populations in this setting will be a challenge. 
 
 
6.4 Segregation of Tconv and Treg Cells Based on CDR3 Sequence 
 
Analysis of selected receptors identified in our repertoire analyses provided 
insight into the composition of the auto-reactive Treg and Teff cell responses.  MOG-
specific Teff cells were highly enriched in the CNS of 1MOG244.2α mice with EAE 
(100% of TCR).  More interestingly, we identified a concentration of MOG-reactive TCR 
among the CNS-infiltrating CD4+Foxp3+ population (6/12 versus 1/8 among 
CD4+Foxp3+ splenocytes).  This functionally confirms the presence of cognate 
autoantigen-reactive Treg cells in the CNS of mice with EAE at high frequency.  Unlike 
Teff cells, which were uniformly MOG-specific, 50% of Vβ8.2+Jβ2.7+ Treg cell TCR 
tested did not recognize MOG.  These cells may be bystanders or effectors specific for 
alternative antigens.  Indeed, Treg cells need not to be specific for cognate autoantigen, 
and response toward tissue-specific or even tissue-unrestricted self antigens released 
during inflammation may potentially stimulate regulatory functions. 
 
Among the MOG-specific T-cells, a length of 12 amino acids and a G at position 
6 in the Vβ8.2+Jβ2.7+ CDR3β was highly correlated with MOG-specificity.  Importantly, 
MOG-specific Teff cells during EAE were fully distinguished by a D or E at position 4, 
and Treg cells by an aliphatic residue, most commonly an A at the same site.  Implicitly, 
Treg and Teff cells during autoimmunity arise from distinct population reservoirs, 
identifiable in 1MOG244.2 retrogenic mouse EAE by the variation at residue 4.  
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Additional structural criteria overlaid on this must be met for MOG-specificity.  It is 
likely that these distinct populations arise from differences in the origin and selection of 
the T-cells, studies of developing thymocytes may help clarify this origin. 
 
Recognition of the acidic versus aliphatic variation in CDR3 of Tconv and Treg 
cell was possible only by examining a narrow slice of the repertoire, one with a fixed 
TCRα and limited to Vβ8.2 and Jβ2.7.  This selective repertoire analysis required the 
production and study of a manipulated mouse strain, the 1MOG244.2α retrogenic mice.  
The consistent identification of specific public TCR within Treg or Tconv cell repertoires 
in these mice indicates consistency in T-cell differentiation patterns within them.  
However, the 1MOG244.2α mice do use a Tcra−/− stem cell recipient, whose thymi 
developed in the absence of normal T-cell maturation.  Further, premature expression of 
TCRα in transgenic or retrogenic systems, such as 1MOG244.2α mice, can influence pTα 
signaling and decrease the efficiency of the DN to DP transition, and thus potentially 
altering the balance of different thymocyte subsets (Aifantis et al., 2006; Borowski et al., 
2004; Huang and Kanagawa, 2004).  We do not find evidence for these alterations 
influencing Treg cell lineage assignment.  Grossly, proportions of Treg cells are normal 
in 1MOG244.2α mice, and overlap among Treg and Tconv cell TCR is similar to that 
observed in other systems (Hsieh et al., 2006; Pacholczyk et al., 2006).  More 
importantly, precursor cells retrogenic for specific Treg or Tconv cell TCR, when heavily 
diluted with wild-type bone marrow and transplanted into wild-type mice, show the same 
lineage predilection as in 1MOG244.2α mice.  This suggests that TCR-driven Treg and 
Tconv cell lineage specification in 1MOG244.2α mice is indicative of the potentials of 
the same TCR in normal thymi as well. 
 
 
6.5 Future Plans to Confirm the Segregation of Treg and Tconv Based on TCR 
Sequence 
 
If the hypothesis that the acidic versus aliphatic variation fundamentally 
influences T-cell lineage assignment is true, exchange of acidic to aliphatic residues or 
vica versa at position 4 may lead to T-cell lineage re-commitment.  We have mutated a D 
or E at position 4 to an A in MOG-specific Tconv TCR, and an A, V, L at same position 
to a D in Treg TCR.  The mutations were confirmed by sequencing.  The idea is to use 
these TCR to repeat the experiment shown in Section 5.2.1.  Specifically the TCR will be 
retrovirally transduced into HPCs from CD45.2+Rag-/- mice, then transplant into 
sublethally irradiated congenic CD45.1+ mice after dilution with CD45.1+ HPCs.  After 8 
weeks, we will analyze Foxp3 expression among CD45.2+ T-cell population, and the 
mice with original TCR will serve as control.  If the hypothesis is correct, Foxp3 
expression will be elevated in mice with Tconv TCR mutated to express an A at position 
4 compared with mice containing original TCR.  On the other hand, Foxp3 expression 
will be diminished in mixed chimera with Treg TCR mutated to express a D at position 4.   
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6.6 Affinity in Treg Responses 
 
 
6.6.1 Models of Treg Repertoire Selection 
 
Treg cells have been alternatively described as recognizing self-antigens with a 
relative higher affinity than Tconv cells, having increased or moderate avidity for self, 
and overlapping in recognition characteristics with pathogenic auto-reactive T-cells.  
Experiments with TCR transgenic mice suggest that precursors develop into the Treg 
lineage when higher avidity interactions with selecting ligands were found (Apostolou et 
al., 2002; Jordan et al., 2001; Kawahata et al., 2002; Walker et al., 2003).  Subsequent 
studies proposed a two-step model that TCR-dependent signals followed by TCR-
independent IL-2 signaling and activation of Stat5 signals (Burchill et al., 2008; Lio and 
Hsieh, 2008; Liston and Rudensky, 2007).  In this model, commitment of Treg cells is 
driven by higher affinity interactions between the TCR and MHC/self-peptide complexes, 
followed by accessory signals (IL-2, B7 and APC etc).  Consequently, Tconv and Treg 
cells express different sets of TCRs that have different affinity to self-antigens (Figure   
6-2A).  However, the actual range of this “higher” affinity for self antigens has never 
been determined, especially in the polyclonal Treg repertoire.  Possibly affinity or avidity 
alone is not an exclusive determinant of Treg lineage assignment.  Even TCRs with weak 
affinities to self antigen may possibly be included in the Treg repertoire.   
 
An alternative presumption is the role of TCR-affinity dependent signals may be 
complementary rather than dominant in Treg lineage selection.  In this model, the 
commitment of Treg precursors occurs prior to thymic selection by TCR, and the TCR-
dependent and/or TCR-independent signals may further complete the Treg lineage 
commitment.  Therefore the final Treg repertoire can be enriched in self-reactive and 
non-reactive TCRs, and the separation of Treg and Tconv cells is achieved by both TCR-
dependent and TCR-independent signals (Figure 6-2B).  This model would explain 
several findings.  First, Foxp3 expression can occur in pre-selected CD4-CD8- 
thymocytes (Pennington et al., 2006).  Second, Treg cells can recognize a wide range of 
foreign antigens and have a diverse repertoire.  Third, increased overlap between Tconv 
and Treg cells was seen in “single-peptide” transgene mice, where all MHCII molecules 
are occupied by one peptide (Pacholczyk and Kern, 2008).   
 
 
6.6.2 Sensitivity and Fine Specificity of MOG-specific Treg and Tconv TCR 
 
Expression of high-affinity cognate antigen on thymic stroma promotes enhanced 
Treg cell differentiation for some TCR (Picca et al., 2006).  MOG is expressed at low 
levels in the thymus (Delarasse et al., 2003).  If MOG sensitivity guides Treg cell 
development, then according to the first (two-step) model introduced above, MOG-
specific Treg should be more sensitive to MOG than specific Tconv cells.  Overall, Treg 
cell TCR showed higher MOG sensitivity than did Teff cell TCR.  However, the 
substantial overlap in Treg and Teff cell TCR sensitivity implied that this was not 
fundamental to their selection (Figure 5-3).  Further, differential fine specificity for MOG 
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Figure 6-2. Generation of specificities of the Treg repertoire.  Reprinted with 
permission.  Pacholczyk, R., and Kern, J. (2008).  The T-cell receptor repertoire of 
regulatory T-cells.  Immunology 125, 450-458. 
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was not identified in Treg and Teff cell TCR.   
 
There are several explanations for the similar MOG response yet different and 
conserved CDR3 features of Treg and Teff cell TCR.  One is that lineage selection for the 
corresponding cell types is not MOG-dependent, but rather that an alternative Ag(s) 
promotes selection, which we will further discuss in Chapter 6.6.1.  Second, the antigen 
sensitivity we measured in the 4G4 system is not the actual affinity to MOG-peptide.  
Theoretically it should be correlated with affinity because of identical CD4 and TCR 
expression on the 4G4 cells, essentially these cells only differed in their CDR3.  
However, direct measurement of affinity should be considered to confirm the results from 
the CD4.4G4 cells, such as by Surface Plasmon Resonance (SPR).  A third possibility is 
that Treg TCR do not necessarily show higher affinity to self-antigen, as described above 
(Figure 6-2B).  That would explain the observation of the low sensitivity of some Treg 
TCR (#9 and #52) in our experiment, and overlapping sensitivity to MOG-peptide among 
Treg and Tconv TCRs.  In addition, when Treg TCRs (#1, #9 and #18) from different 
“sensitivity windows” were tested for giving rise to Treg cells in mixed-BM chimeric 
mice, Treg cells developed with all three TCRs, up to ~30% at very low frequencies.  No 
deletion was seen in #1 receptor, which showed highest sensitivity and maximal response 
in CD4.4G4 cells.   
 
It will also be important to determine how the sensitivity or affinity of Treg TCR 
influences their protective abilities.  To address this, further in vivo studies should be 
performed on the Treg TCRs.  To determine their actual function in EAE, we will 
generate mixed-BM chimeras with low or high-sensitivity receptors, and challenge them 
with MOG peptide, to see whether there are differences in the ability of these receptors to 
protect mice from EAE.   
 
 
6.7 Antigen Specificity in Regulatory T-cell Responses 
 
 
6.7.1 Does MOG-specific T-cell Cross-react with Alternative Self-antigen Which 
Mediates Thymic Selection? 
 
In order to mount a rapid and efficient immune response against invading 
pathogens, TCRs have evolved a high level of antigen cross-reactivity and recognize 
multiple different peptides bound to MHC molecules.  Cross-reactivity is necessary for 
T-cell development and is critical given the fixed size of the T-cell repertoire relative to 
the vast universe of potential antigens (Bhardwaj et al., 1993; Evavold et al., 1995; 
Mason, 1998; Maverakis et al., 2001; Wilson et al., 2004; Wucherpfennig and 
Strominger, 1995).  Mason et al. estimated that each T-cell is capable of reacting with 
~106 different MHC-associated peptide epitopes (Mason, 1998), and Hiemstra et al. 
further confirmed the estimation through deduction of effective concentrations of agonist 
ligands in a peptide-“gemisch” (Hiemstra et al., 1998).  Although the possible antigens 
are non-self peptides, based on these estimates it must be considered that any particular 
TCR will likely be specific for more than one self-antigen.  Molecular mimicry and cross 
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reactivity is frequently found in autoimmunity.  An elegant example is that mice 
developed EAE after immunization with peptide of hepatitis B virus, which shared a 
sequence of six consecutive amino acids in common with MBP (Wucherpfennig and 
Strominger, 1995).  Subsequent studies showed that only a few critical amino acids 
serving as contact residues were needed to be shared by two antigenic peptides in order to 
elicit cross-reactivity (Evavold et al., 1993; Kersh and Allen, 1996; Madrenas et al., 
1995).   
 
In one study, MOG-specific 2D2 TCR transgenic mice developed EAE in the 
absence of MOG because 2D2 T-cells cross react with neurofilament-M (NF-M18-30, 
TETRSSFSRVSGS), which shares crucial contact amino acids with MOG35-55 
(MEVGWYRSPFSRVVHLYRNGK) (Krishnamoorthy et al., 2009).  We hypothesized 
that the Treg cell identified here could be selected by NF-M18-30 in thymus originally, and 
could cross react with MOG35-55.  As a first step to test this hypothesis, we transduced the 
original MOG-specific TCR and their counterpart mutations into CD4.4G4 cells, then 
examined their responsiveness to NF-M18-30 and MOG35-55 by IL-2 production.  If NF-
M18-30 is responsible for Treg selection, Treg TCRs recognize NF-M and may have higher 
sensitivity than Tconv TCR.  Further, the D/E versus A/V/L variation is responsible for 
T-cell lineage assignment, mutation in Treg TCR should lead to the decreased response to 
NF-M18-30, whereas mutation in Tconv TCR may enhance their recognition to NF-M18-30.  
So far pilot experiments were performed on 12 receptors.  4 out of 6 mutated Tconv TCR 
showed increased sensitivity, and 4 out of 6 mutated Treg TCR showed decreased 
sensitivity to NF-M.  We will confirm this result by testing more receptors.   
 
 
6.7.2 What Do Non-MOG-specific Treg TCR Recognize?  
 
Epitope spreading is when the specificity of T and B-cells in the immune response 
spreads or switches from the initiating epitope to other epitopes, including self epitopes, 
(Vanderlugt and Miller, 2002).  This phenomenon has been observed in PLP139-151 
induced EAE in the SJL mouse, where after priming SJL mice with PLP139-151, the 
immune response switches from anti-PLP139-151 to anti-PLP178-191 and anti-MBP84-104 
during the course of EAE (McRae et al., 1995; Vanderlugt et al., 2000).  These findings 
were based on total CD4+ T-cells, mainly effector T-cells.  In MOG-EAE epitope spread 
has not been seen in the Teff response.  Whether epitope spreading exists in Treg cells in 
MOG-EAE, however, remains uncertain.   
 
In the CNS of 1MOG244. mice, we identified six receptors (50%) from the 
Treg population that were not MOG-specific.  Kuchroo et al. showed that ~7% and 34% 
CNS-infiltrating Treg are MOG tetramer-positive in the peak and recovery phase, 
respectively, and concluded that the rest of Treg are bystanders (Korn et al., 2007).  Why 
do these “bystander” Treg cells accumulate in CNS?  Do they recognize other self-
antigen(s) because of epitope spreading?  To answer this question, we can test whether 
these receptors react with NF-M18-30 using CD4.4G4 hybridomas.   
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The second question is whether these non-MOG-specific Treg cells play a role in 
EAE protection.  We tried to generate retrogenic mice expressing a single TCR, but the 
number of monoclonal Treg cells acquired from single TCR-retrogenic mice was very 
low presumably because of niche saturation.  We also tried to convert Tconv cells 
isolated from these retrogenic mice into Treg with TGF- and high dose of IL-2 and 
injected the induced Treg cells into Rag-/- mice, to test EAE protection.  Unfortunately, it 
was much more difficult to expand small numbers of clonal cell from retrogenic mice 
than Tconv cells from wild-type, and we also found the converting efficiency was 
receptor dependent and often poor.  Further studies will be needed to optimize this.  
Hsieh’s group created mixed-bone marrow chimeras with varying ratios of polyclonal 
progenitor cells and progenitor cells transgenic for Treg cell-derived TCRs.  We will also 
generate similar mixed-bone marrow chimeras with retrovirally transduced HPCs 
expressing “bystander Treg TCR” using HPCs are from Foxp3-GFP x Rag-/- mice.  After 
8 weeks transplantation, we will examine Treg with transduced TCR in peripheral blood 
by GFP.  Positive mice will be challenged with MOG peptide and EAE will be followed 
to determine if the retrogenic Treg diminish disease severity.   
 
In summary, we assessed Treg and Tconv repertoires in MOG-EAE.  Under 
inflammatory conditions, the Tconv used a repertoire distinct from that of Treg, though 
the repertoires overlapped.  The extent of this overlap was not significantly increased 
with immunization.  Both MOG-specific Treg and Tconv with distinct repertoires are 
concentrated within the CNS during EAE, though infiltrating Treg seemingly possess a 
broader spectrum of antigen specificities.  Examination of MOG-specific Treg and Teff 
cell TCR with a fixed TCRα and restricted TCRβ usage failed to find evidence for 
sensitivity or fine specificity for MOG influencing Treg versus Tconv cell lineage 
assignment, but did reveal lineage segregation based on conserved CDR3 features.  Our 
results imply that ontogenically distinct Treg and Tconv cell repertoires during MOG-
EAE and argue against more than limited plasticity between Treg and Tconv cells during 
the autoinflammatory response.  
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